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ABSTRACT

Devireddy, Swathi. Ph.D., Purdue University, December 2015. The Organization of
Mitochondrial Quality Control and Life Cycle in the Nervous System in vivo in the
Absence of PINK1. Major Professor: Peter J. Hollenbeck.

Maintenance of healthy mitochondria is crucial in cells, such as neurons, with
high metabolic demands, and dysfunctional mitochondria are thought to be selectively
degraded. Studies of chemically uncoupled cells have implicated PINK1 mitochondrial
kinase, and Parkin E3 ubiquitin ligase in targeting depolarized mitochondria for
degradation. However, the role of the PINK1/Parkin pathway in mitochondrial turnover is
unclear in the nervous system under normal physiological conditions, and we
understand little about the changes that occur in the mitochondrial life cycle when
turnover is disrupted. Here, I evaluated the nature, location and regulation of quality
control in vivo using quantitative measurements of mitochondria in Drosophila nervous
system, with deletion and overexpression of genes in the PINK1/Parkin pathway. I tested
the hypotheses that impairment of mitochondrial quality control via suppression of PINK1
function should produce failures of turnover, accumulation of senescent mitochondria in
the axon, defects in mitochondrial traffic, and a significant shift in the mitochondrial
fission-fusion steady state. Although mitochondrial membrane potential was diminished
by PINK1 deletion, I did not observe the predicted increases in mitochondrial density or
length in axons. Loss of PINK1 also produced specific, directionally-balanced defects in
mitochondrial transport, without altering the balance between stationary and moving
mitochondria. Somatic mitochondrial morphology was also compromised. These results
strongly circumscribe the possible mechanisms of PINK1 action in the mitochondrial life
cycle, and also raise the possibility that mitochondrial turnover events that occur in
cultured embryonic axons might be restricted to the cell body in vivo, in the intact
nervous system.
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CHAPTER 1. INTRODUCTION

1.1 Mitochondrial Life Cycle in Neurons
1.1.1 Significance of Functional Mitochondria in Neurons
Neurons, like other cells, depend on mitochondria for their survival and normal
function. Mitochondria perform diverse functions including generating ATP, controlling
the release of apoptotic signals and buffering excess cytosolic calcium ions. To provide
the ATP required for cellular activities, mitochondria harness the energy released by the
oxidation of nutrients via the electron transport chain (ETC) and oxidative
phosphorylation (OXPHOS). The mitochondrial inner membrane contains the enzymatic
complexes required for ETC and OXPHOS processes. In the ETC, as electrons are
transferred from substrates through complexes I to IV, protons are pumped out of
mitochondrial matrix into the intermembrane space. This establishes an electrochemical
gradient, consisting of both a negative membrane potential (IMP or ΔΨ m ) inside the
mitochondrial matrix, and a proton gradient (ΔpH) across the mitochondrial inner
membrane. This electrochemical potential across the membrane has potential energy
that is harnessed during the inward flow of protons into mitochondrial matrix through
ATP synthase complex. Thus, the rate of ATP production depends on the mitochondrial
inner membrane potential (IMP) (Benard and Rossignol, 2008).
Neurons rely heavily on mitochondrial aerobic ATP production, from which they
derive the majority of ATP needed for their high metabolic rate. Accordingly,
mitochondria are distributed and concentrated in neuronal regions with high metabolic
activity such as synapses, active growth cones, nodes of Ranvier, myelination zones
etc., to meet local energy demands (Hollenbeck and Saxton, 2005). The enormous size
and surface area of neurons result in high levels of ATP being consumed for the
maintenance of ionic gradients and membrane potential associated with Na+/K+ pumps
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(Knott et al., 2008). In addition, because of their highly polarized and complex
morphology, neurons depend heavily on axonal transport that utilizes ATP and motor
proteins to deliver materials and organelles to all parts of the cell. At distal synaptic
regions, mitochondria supply ATP for many events of the synaptic vesicle (SV) cycle
including: SV loading of neurotransmitters (NTs); myosin mediated mobilization of SV;
and the SV fusion with plasma membrane for NT release into synaptic cleft (Vos et al.,
2010). Moreover, mitochondria are known to sequester excess cytosolic calcium ions in
the presynaptic terminal during synaptic transmission (Vos et al., 2010). Thus many
mitochondrial functions are known to be essential for the life of the neuron.
In addition to ATP production, mitochondria generate reactive oxygen species
(ROS), mainly as a byproduct of ETC. During the process of ETC, superoxide radicals
(O 2 •−) can be generated at complexes I and III, by anomalous transfer of electrons to
oxygen (Turrens, 2003). In healthy mitochondria, ROS are normally maintained at low
steady state levels due to their reduction by mitochondrial antioxidant enzymes including
superoxide dismutase and glutathione peroxidase. However, if mitochondria are
damaged and become dysfunctional, antioxidant enzymes may become insufficient to
the task, causing the accumulation of ROS. This causes additional damage to proteins,
lipids, and nucleic acids, eventually leading to gross oxidative stress (Turrens, 2003).
Oxidative stress is thought to play an important role in age-related progressive
neurodegenerative diseases such as Parkinson’s disease (PD) and Amyotrophic lateral
sclerosis (ALS) (Turrens, 2003; Barnham et al., 2004).
Given the critical dependence of neurons on various mitochondrial functions,
mitochondrial dysfunction can be expected to have severe effects on neuronal function
and survival. Indeed, mutations affecting mitochondrial function have been shown to be
associated with several neurodegenerative diseases including PD, hereditary spastic
paraplegia (HSP), Charcot-Marie-Tooth type2A (CMT2A) disease etc., (Tatsuta and
Langer, 2008).
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1.1.2 Mitochondrial Quality Control
Cells employ quality control mechanisms at the molecular and the organelle level
to maintain the healthy, functional mitochondrial population (Rugarli and Langer, 2012).
Mitochondrial protein quality control is initiated mainly in response to irreversible
mitochondrial protein damage or heat stress, and utilizes molecular chaperones and
AAA proteases. Chaperones help in the proper folding of newly synthesized, imported
pre-proteins. Most AAA proteases specifically identify misfolded or damaged proteins
and degrade them into small peptides, which are eventually expelled from mitochondria
for further degradation to amino-acids by cytoplasmic oligopeptidases (Tatsuta and
Langer, 2008). At the organelle level, mitochondria maintain their functional status by
frequently undergoing fusion and fission. Inhibition of mitochondrial fusion in fibroblast
cells results in reduced mitochondrial function and respiratory capacity (Chen et al.,
2005). These mitochondrial defects can be rescued by induction of mitochondrial fusion,
suggesting that fusion helps in the maintenance of functional mitochondria in cells (Chen
et al., 2005; Detmer and Chan, 2007). However, dysfunctional mitochondria are inhibited
from fusing with the healthy mitochondrial network, and are then thought to be
eliminated by the process of mitochondrial autophagy, termed “mitophagy” (Twig et al.,
2008b; Rugarli and Langer, 2012).
An additional issue for a large neuronal cell with complex morphology is the
localization or compartmentalization of the different parts of the mitochondrial life cycle:
biogenesis, transport, changes in metabolic state, fission-fusion, and turnover. It is
presumed that in neurons, as in other cells, these features of the mitochondrial life cycle
are carried out in a coordinated fashion so as to maintain a highly functional
mitochondrial population, minimizing the effects of somatic mtDNA mutations, protein
denaturation, etc. This coordination is commonly referred to as mitochondrial quality
control. However, we still know very little about how neuron coordinates the events of
mitochondrial life cycle over time and distance to maintain a functional mitochondrial
population.
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1.1.3 The Mitochondrial Life Cycle in Neurons
The mitochondrial life cycle in neurons consists of multiple, coordinated events that
encompass mitochondrial biogenesis, axonal transport, fission-fusion and turnover.
Neurons have a polarized structure including a cell soma, dendrites, an axon and
synaptic terminals. The somatic compartment is connected to synaptic region by an
extremely long, thin axon which can extend up to a meter in human motor neurons. The
majority of protein synthesis and degradation machinery is concentrated in the neuronal
somatic compartment, near the nucleus. Consequently, newly synthesized proteins and
organelles are delivered from the soma to the axonal and synaptic regions by
anterograde axonal transport. The damaged, worn-out materials and organelles are
moved by retrograde transport back to the soma for recycling and degradation (Saxton
and Hollenbeck, 2012).
1.1.4 Mitochondrial Biogenesis
Mitochondria possess their own genome that encodes 13 essential protein subunits of
ETC, along with 2 rRNAs and 22 tRNAs required for mitochondrial protein synthesis
inside the organelle. Each mitochondrion contains several copies of mitochondrial DNA
(mtDNA). Mitochondrial DNA is packaged along with mtDNA-associated proteins into
nucleoid structure. The core components of nucleoid structure mainly include proteins
and enzymes required for mtDNA replication, and transcription (Gilkerson et al., 2013).
However, the majority of the mitochondrial proteins are encoded by nuclear genome,
including mitochondrial structural proteins and proteins required for mtDNA replication
and transcription. These nuclear DNA encoded proteins are translated in the cytosol,
and imported into mitochondria through protein translocase complexes, TOM and TIM,
present in outer and inner mitochondrial membrane (Jornayvaz and Shulman, 2010).
Thus mitochondrial biogenesis requires close coordination between mitochondrial and
nuclear genomes. This coordination is not fully understood, but it is known to be
regulated by transcriptional activators including PPAR (peroxisome proliferator-activated
receptor)-γ coactivator-1α (PGC-1α) along with transcriptional coactivator nuclear
respiratory factors (NRF-1 and NRF-2). PGC-1α activates NRFs, which then induce the
expression of mitochondrial transcription factor A (Tfam). This nuclear-encoded Tfam is
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imported into mitochondria, where it initiates the transcription of mtDNA (Duchen, 2004;
Jornayvaz and Shulman, 2010). Because of this complex coordination between
mitochondrial and nuclear genomes, mitochondrial biogenesis is thought to occur
predominantly in cell soma, near the nucleus. Given the lengthy dimensions of neuron,
the newly generated mitochondria are then delivered from cell soma to active neuronal
regions by fast axonal transport. However, mitochondrial biogenesis is not restricted to
somatic compartment, and evidence from embryonic neurons indicates that it can also
occur in axons (Amiri and Hollenbeck, 2008).
1.1.5 Mitochondrial Axonal Transport
Because of the size and compartmentalized structure of neurons, an ATP supply
provided by diffusion from the soma is entirely insufficient to support neuronal activities.
Therefore, mitochondria are positioned all along the axon and are also concentrated at
distal synaptic regions, active growth cones, nodes of Ranvier, myelinated regions etc.,
to manage local metabolic demands (Hollenbeck and Saxton, 2005). Compared to other
axonal cargoes, mitochondria show distinctive saltatory and bidirectional movements in
the axon. Mitochondrial movements include stops, starts and small reversals in direction
(Hollenbeck and Saxton, 2005; Saxton and Hollenbeck, 2012). However, mitochondria
spend the major fraction of time moving in their primary direction compared to pauses or
reversals which result in their strong net movement in one particular direction (Morris
and Hollenbeck, 1993; Pilling et al., 2006; Shidara and Hollenbeck, 2010). In addition,
mitochondrial movement has been shown to be highly regulated in response to regional
physiological requirements of neurons (Morris and Hollenbeck, 1993; Hollenbeck, 1996).
In an actively growing axon, mitochondria show net anterograde movement and are
retained in high densities near the growth cone region. However, when the axonal
growth has been disrupted either physically or pharmacologically, mitochondria showed
net retrograde movement and are uniformly dispersed along the axon, far from the
growth cone region (Morris and Hollenbeck, 1993).
These complex movements are accomplished with the help of trafficking
machinery that includes molecular motor proteins that carry mitochondria along
cytoskeletal tracks. Long distance axonal transport of mitochondria occurs on
microtubule tracks (MTs) that are arranged with their plus ends towards the synaptic
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terminals and minus ends towards the cell body. Plus end-directed conventional kinesin
(kinesin-1) acts as the major anterograde motor and minus end-directed dynein acts as
the retrograde motor. Inhibition of mitochondrial movement in the absence of kinesin-1
and dynein in the Drosophila nervous system suggests that kinesin-1 and dynein act as
the major motors in the axonal transport of mitochondria (Pilling et al., 2006).
In addition to MTs, actin filaments have also been shown to be involved in
mitochondrial axonal transport based on the observation of mitochondrial motility after
the pharmacological disruption of MTs (Morris and Hollenbeck, 1995). Thus it has been
postulated that actin filament based transport might facilitate the short range movement
of mitochondria locally in regions that lack MTs (Morris and Hollenbeck, 1995). However,
disruption of Myosin V in Drosophila cultured neurons caused a decrease in pausing
time and an increase in the mitochondrial movement suggesting a role for myosin
motors in mitochondrial docking by opposing the MT based transport (Pathak et al.,
2010) (Figure 1.1).

Figure 1.1 Tracks and motors in mitochondrial axonal transport. (a) Mitochondria
are transported on microtubule tracks for long distances in axons by anterograde
Kinesin-1 and retrograde dynein motor proteins. (b) Actin filament based Myosin V motor
protein assists in stationary docking of mitochondria by opposing microtubule based
organelle movements. (Figure is adapted and modified from Saxton and Hollenbeck,
2012).
Mitochondrial axonal transport is also specifically regulated by intracellular
signals, perhaps to ensure the efficient delivery of mitochondria to appropriate locations.
Application of nerve growth factor (NGF)-coated beads to axonal regions has been
shown to cause the local halting of mitochondrial movement near the NGF signal.
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However, the NGF mediated mitochondrial halting is disrupted by the inhibition of
phosphoinositide-3 kinase (PI-3 kinase) pathway suggesting that the NGF/PI-3 kinase
signaling pathway facilitates mitochondrial docking on actin filaments (Chada and
Hollenbeck, 2003; Chada and Hollenbeck, 2004). In addition, a variety of kinase
signaling pathways have been shown to regulate fast axonal transport of organelles by
phosphorylating specific motor protein subunits. GSK3 and CK2 have been shown to
phosphorylate kinesin light chains (KLCs) causing the release of kinesin motor from the
organelle, thereby inhibiting anterograde transport (Morfini et al., 2002; Morfini et al.,
2004). Phosphorylation of kinesin heavy chain (KHC) by JNK3 and p38 MAPK has been
shown to inhibit the motor head domain from interacting with MTs thus disrupting
anterograde transport (Morfini et al., 2009a; Morfini et al., 2013).
Axonal transport is also regulated by adaptor or linker proteins that associate an
organelle to its motors. Genetic screens in Drosophila designed to identify genes
required for synaptic transmission surprisingly uncovered the function of Milton (Stowers
et al., 2002). Drosophila milton mutants have a complete lack of mitochondria in their
axons and synaptic terminals, resulting in synaptic functional deficits. The association of
Milton with both mitochondria and kinesin suggested a role in mediating the axonal
transport of mitochondria (Stowers et al., 2002). Similarly, Drosophila miro mutants have
also shown a complete lack of mitochondria in synapses, causing defective synaptic
transmission (Guo et al., 2005). In the absence of Miro, mitochondria accumulate in cell
bodies, with a sparse distribution in axons, indicating a role for Miro in mitochondrial
transport (Guo et al., 2005). Similar to miro null mutants, deletion of N-terminal GTPase
domain of Miro also causes the mitochondrial accumulation in cell bodies with very few
mitochondria entering the axons (Babic et al., 2015). This suggests that N-terminal
GTPase domain of Miro plays a crucial role in the transport of mitochondria into axons
(Babic et al., 2015). Milton, via an interaction with Miro, has been shown to act as an
adaptor protein complex that recruits kinesin-1 motor onto the mitochondrial surface
(Glater et al., 2006). In addition to rho-GTPase like activity, Miro possesses calcium
binding EF-hand domains, and has been shown to regulate mitochondrial transport
machinery in response to elevated intracellular Ca2+ ions. Binding of Ca2+ to EF-hands
causes a conformational change in Miro that results in its direct binding to the kinesin-1
motor domain, thereby preventing the kinesin-1 motor from interacting with MTs (Wang
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and Schwarz, 2009). Thus, Miro has been proposed to have a role in halting
mitochondrial movement in response to the elevated Ca2+ levels in neurons (Wang and
Schwarz, 2009).
Impaired mitochondrial transport is known to be associated with the
pathogenesis of multiple neurodegenerative diseases including Huntington’s disease
(HD), hereditary spastic paraplegia (HSP), and familial amyotrophic lateral sclerosis
(ALS) (De Vos et al., 2008; Sheng and Cai, 2012). Mitochondrial dysfunction and axonal
transport defects have been shown to occur well before the axonal degeneration
phenotype in disease models (Ferreirinha et al., 2004; Shidara and Hollenbeck, 2010). A
HSP mouse model that lacks paraplegin, a mitochondrial AAA ATPase protein, shows
disrupted mitochondrial structure, and impaired axonal transport, both appearing well
before the gross phenotype of distal axonal degeneration of spinal and peripheral nerves
(Ferreirinha et al., 2004). Recent studies on a Friedreich Ataxia Drosophila model
deficient in frataxin, an Fe-S cluster chaperone of respiratory chain complexes,
demonstrated the mitochondrial dysfunction, and retrograde transport defects, all
occuring well before distal axonopathy (Shidara and Hollenbeck, 2010). These reports
clearly suggest that mitochondrial axonal transport defects are related to dying-back
neuropathy.
1.1.6 Mitochondrial Fusion - Fission
Mitochondria are highly dynamic organelles which undergo continuous cycles of
fusion and fission to maintain their function and morphology. Mitochondrial fusion
involves the sequential fusion of both the outer and inner membranes of two adjacent
mitochondria. Fusion of outer mitochondrial membranes is carried out by Mitofusin
proteins (Mfn1 and Mfn2 in mammals) present on adjacent mitochondria, while
subsequent to this, the fusion of inner membranes is mediated by optic atrophy protein 1
(Opa1) (Figure 1.2). Complete fusion results in the mixing of the mitochondrial matrix
contents. Disruption of mitochondrial fusion by the deletion of either mitofusins or Opa1
in mouse embryonic fibroblasts (MEFs) results in a heterogenous population of
mitochondria with varied bioenergetic status, and the majority of mitochondria lose
mtDNA nucleoids due to lack of re-distribution in the absence of fusion (Chen et al.,
2005; Chen et al., 2007). Consistent with this, mitochondria show a reduction in
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respiratory activities and low oxygen consumption rates in the absence of fusion (Chen
et al., 2005; Chen et al., 2007). These studies clearly suggest that mitochondrial fusion
helps in the maintenance of mitochondrial function via the mixing and re-distribution of
mitochondrial contents. Because mitochondria are the major source of ROS, mtDNA is
particularly prone to ROS damage, and accumulates somatic mutations. Mutations in
mtDNA can cause the loss of mitochondrial ETC protein subunits or affect their activity,
resulting in mitochondrial dysfunction. In such conditions, fusion of mitochondria having
mutations in different genes has been shown to restore respiratory function in HeLa cells
by functional complementation (Ono et al., 2001; Westermann, 2010; Westermann
2012). Thus mitochondrial fusion plays a crucial role in the maintenance of mitochondrial
function via complementation of gene products.
Mitochondrial fission is carried out by GTPases - dynamin-related protein 1
(Drp1) and mitochondrial fission protein (Fis1). Fis1 is present on the surface of outer
mitochondrial membrane and recruits cytosolic Drp1 onto the mitochondrial membrane
at the site of impending scission (Figure 1.2). Drp1 assembles in the form of a spiral
around the mitochondrial constriction site and divides the organelle into two, which
requires GTP hydrolysis (Westermann, 2010; Mishra and Chan, 2014). Disruption of
fission results in mitochondrial dysfunction, oxidative damage, and reduced mitophagy in
mammalian cells (Parone et al., 2008; Twig et al., 2008a), suggesting that fission helps
to maintain mitochondrial function, probably by segregating damaged mitochondria for
degradation (Chen and Chan, 2009).

Figure 1.2 Proteins involved in mitochondrial fusion and fission. A) Mitofusin (Mfn)
proteins present on adjacent mitochondria mediate the fusion of mitochondrial outer
membrane. Fusion of inner membrane is carried out by optic atrophy protein Opa1. B)
Mitochondrial fission protein Fis1 on the mitochondrial outer membrane recruits the
cytosolic dynamin-related protein Drp1 to the scission site. Drp1 forms as a spiral
structure and constricts the mitochondrial membrane resulting in organelle fission.
(Figure is adapted and modified from Chen and Chan, 2005).
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Steady-state mitochondrial morphology depends on the balance between fusion
and fission rates in cells. Genetic disruption of either fusion or fission proteins has been
shown to dramatically alter the mitochondrial morphology in mammalian cells (Detmer
and Chan, 2007; Amiri and Hollenbeck, 2008). Impaired fission by the depletion of Drp1
has resulted in highly interconnected network like morphology in COS-7 cells (Smirnova
et al., 2001). On the other hand, impaired fusion by the knockdown of Mfns has caused
the formation of small fragmented mitochondria in MEFs (Chen et al., 2003). In addition,
mitochondrial morphology has been shown to change in response to the altered
physiological state of the cell. When fibroblasts are deprived of nutrients, mitochondria
become elongated and interconnected forming a network mainly due to the downregulation of Drp1 activity. Elongated mitochondrial morphology has been shown to
correlate with high respiratory capacity, which supplies energy for cell survival during
starvation (Gomes et al., 2011; Rambold et al., 2011). Moreover, elongated mitochondria
are not easily engulfed by autophagic vesicles, and thus are spared from starvationinduced autophagy (Gomes et al., 2011; Rambold et al., 2011).
Mitochondrial fission-fusion processes have been proposed to play a crucial role
in mitochondrial quality control, based on recent studies involving the long term tracking
of single mitochondria in pancreatic INS1 and β-cells (Twig et al., 2008a). Mitochondrial
fission-fusion processes occur continuously, with each fusion event followed by a fission
event. Very often, fission generates two functionally distinct daughter mitochondria: one
with a hyperpolarized and the other with a depolarized inner membrane. The
hyperpolarized mitochondrion has a high probability of undergoing fusion with healthy,
functional mitochondrial network. However the depolarized mitochondrion is prevented
from undergoing fusion due to the downregulation of fusion protein Opa1 activity. Thus it
has been proposed that fission followed by selective fusion helps to segregate damaged
mitochondria for mitophagic degradation (Twig et al., 2008a; Twig et al., 2008b).
Given the crucial role of mitochondrial fusion-fission processes in the
maintenance of mitochondrial function and in quality control, any defects in mitochondrial
dynamics will affect neuronal function and survival. This is very evident as mutations in
Mfn2 and Opa1 have been shown to cause human neurodegenerative diseases,
including CMT2A and DOA, respectively (Chan, 2006). Disruption of mitochondrial

11
fusion due to loss of Mfn2 function in mouse cerebellum has caused mitochondrial
structural defects including disintegrated cristae, and ETC defects (Chen et al., 2007).
This indicates the role of mitochondrial fusion in the maintenance of mitochondrial
function via content mixing and re-distribution of mitochondrial contents. Deletion of Drp1
has shown abnormal mitochondrial morphology and respiratory defects in mouse
cerebellar purkinje cells (PC) (Kageyama et al., 2012). These defects become
progressively more severe with age, and appeared before PC neurodegeneration.
Moreover, accumulation of LC3 mitophagy marker around mitochondria indicates the
impaired degradation of mitochondria. Interestingly, treatment with antioxidants has
restored the mitochondrial defects and PC neurodegeneration in the absence of Drp1.
These results suggest that mitochondrial fission acts in mitochondrial quality control via
the segregation of the damaged mitochondria, thereby protecting neuronal cells from the
accumulation of oxidative damage (Kageyama et al., 2012). Deletion of Drp1 fission
protein in mouse neuronal cultures produces a significant reduction in mitochondrial
entry into neurites, implying the role of fission in generating small transportable
mitochondria for their proper distribution in neurons (Ishihara et al., 2009). Absence of
Drp1 in the Drosophila nervous system gives rise to the elongated mitochondria in the
proximal and distal axons, suggesting that mitochondrial fission occurs in axons in vivo
(Verstreken et al., 2005). In cultured vertebrate peripheral neurons, overexpression of
the fusion protein Mfn1 or downregulation of the fission protein Drp1 resulted in an
elongated mitochondrial morphology in distal axons. This clearly indicates that the
mitochondrial fusion-fission processes indeed occur in axons, not just in the cell body
(Amiri and Hollenbeck, 2008). However, it is worth noting that the rate of fusion-fission is
~6 fold lower in axons than in the somatic compartment (Cagalinec et al., 2013).
1.1.7 The Intricate interrelationship of Mitochondrial Metabolic Function, Transport, and
Fission - Fusion
Axonal transport depends heavily on mitochondrial aerobic ATP production, as
the cargo-delivering motor proteins require ATP for their activity. A variety of disruptions
of mitochondrial metabolism have been shown to affect mitochondrial transport. In
cultured vertebrate neurons, treatment with mitochondrial uncouplers or inhibition of ATP
synthase or the electron transport chain diminished mitochondrial transport (Hollenbeck
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et al., 1985; Rintoul et al., 2003; Miller and Sheetz, 2004), while complex III inhibition
transiently increased retrograde transport (Miller and Sheetz, 2004). These studies
indicate that mitochondrial metabolic function and axonal transport are related.
Numerous studies indicate that the mitochondrial fusion-fission processes and
axonal transport are inter-related. Disruption of the mitochondrial fission protein Drp1 in
the Drosophila nervous system has resulted in sparse distribution of mitochondria at
neuromuscular junctions (NMJs) implying defects in mitochondrial transport (Verstreken
et al., 2005). This transport defect is attributed to the disruption of Drp1-dependent
fission that normally generates mitochondria amenable for axonal transport. The
mitochondrial fusion protein Mfn2 has been shown to mediate motility in cultured dorsal
root ganglion (DRG) neurons (Baloh et al., 2007), via its interaction with Miro and Milton,
the kinesin-linker proteins (Misko et al., 2010). On the other hand, overexpression of
Miro increases mitochondrial lengths in cultured rat cortical neurons (Saotome et al.,
2008) and in Drosophila motor axons in vivo (Russo et al., 2009). Knock-down of Miro
has decreased mitochondrial lengths in cultured rat cortical neurons (Cagalinec et al.,
2013). In addition, enhanced mitochondrial motility by Myosin-V knock-down has
resulted in elongated mitochondria in axons of Drosophila cultured neurons (Pathak et
al., 2010). Recently, detailed analyses of mitochondrial fusion-fission in cultured neurons
suggest that the rate of fusion events increases with enhanced motility, whereas fission
is triggered by an increased mitochondrial length, thereby help maintain the
mitochondrial length in axons (Cagalinec et al., 2013).
Thus, although the mechanisms remain unclear, it is apparent that there is a
complex interplay among mitochondrial function, axonal transport, and fusion-fission
processes.
1.1.8 Mitochondrial Turnover by Mitophagy
Autophagy is a catabolic process that is triggered to provide essential molecular
building blocks when cells are deprived of nutrients during starvation. During autophagy,
cytosolic contents including a variety of organelles, and protein aggregates, are engulfed
into double membranous autophagosomes. These autophagosomes then fuse with
lysosomes to deliver the contents for enzymatic digestion and recycling. Unlike this non-
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selective autophagy that occurs during starvation, selective autophagy occurs under
nutrient rich conditions to eliminate and recycle damaged or excess organelles in cells.
Several

cargoes

including

endoplasmic

reticulum

(reticulophagy),

peroxisomes

(pexophagy), foreign pathogens (xenophagy), mitochondria (mitophagy), are known to
be specifically targeted and eliminated by selective autophagy process (Kim et al., 2007;
Goldman et al., 2010).
So far, ~31 essential autophagy-related (ATG) genes have been identified from
yeast genetic screens (Mizushima, 2007). The key ATG genes, essential for all types of
autophagy including the formation and maturation of autophagosomes, are evolutionarily
conserved from yeast to mammals (Kim et al., 2007; Mizushima, 2007; Suzuki and
Ohsumi, 2007). Some of the core molecular machinery involved in general autophagy
has been shown to be required for mitophagy. Deletion of autophagy-related genes
(ATG1, ATG6, ATG8, and ATG12) results in the accumulation of mitochondria in yeast
(Zhang et al., 2007). Moreover, when these ATG deficient yeast strains are forced to
depend on mitochondrial oxidative phosphorylation by growing them on non-fermentable
medium, several mitochondrial functional defects become manifest, including low IMP,
low ETC activity, and high levels of ROS (Zhang et al., 2007). This indicates a key role
for autophagy in mitochondrial quality control. In addition, disruption of autophagy by
Atg7 deletion in mice compromises mitochondrial functions, producing respiratory
defects and high ROS levels in skeletal muscle (Wu et al., 2009), and suggesting a role
for Atg7 in mitochondrial maintenance. Atg32, an outer mitochondrial membrane protein,
identified from yeast genome-wide screening, has been shown to act as a mitophagy
receptor for selective degradation of mitochondria (Ishihara and Mizushima, 2009; Kanki
et al., 2009; Okamoto et al., 2009). Atg32 possesses two motifs to interact specifically
with Atg11 and Atg8, which then mediate the formation of autophagosomal isolation
membrane around mitochondria for degradation (Liu et al., 2014; Wei et al., 2015).
Although mammalian homologues of Atg32 are not identified yet, there is abundant
evidence for the occurrence of mitophagy in mammalian cells. For example, in cultured
rat hepatocytes, GFP-LC3 (a mammalian homologue of Atg8) autophagic vesicles are
formed selectively around depolarized mitochondria after photodamage (Kim et al.,
2007; Kim and Lemasters, 2011). This indicates that damaged mitochondria are
selectively targeted for mitophagy.
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Mitophagy has also been shown to occur during specific developmental
processes, including erythrocyte maturation and oocyte fertilization. During oocyte
fertilization, sperm mitochondria are specifically targeted and eliminated by mitophagy
(Shitara et al., 2000; Al Rawi et al., 2011; Sato and Sato, 2011). During the maturation of
erythroid cells, the Bcl-2 related protein Nix (BNIP3L), an outer mitochondrial membrane
protein, has been shown to act as a mitophagy receptor for the selective elimination of
mitochondria. Loss of Nix function inhibits the clearance of mitochondria in reticulocytes
(Schweers et al., 2007; Sandoval et al., 2008). In particular, Nix has been shown to
induce mitochondrial depolarization and specifically incorporate the mitochondria into
autophagosomes for mitophagy (Schweers et al., 2007; Sandoval et al., 2008). In
addition, Nix has been shown to promote autophagosome formation by recruiting
LC3/GABARAP protein onto depolarized mitochondria (Novak et al., 2010). All these
studies on mitophagy indicate that loss of mitochondrial membrane potential probably
acts as a signal for selective elimination of mitochondria.
1.2 PINK1 - Parkin Pathway in Mitochondrial Turnover
In mammalian cells, PTEN-induced putative kinase 1 (PINK1) and the E3
ubiquitin ligase parkin have been characterized to selectively target depolarized
mitochondria for turnover. Genes encoding parkin, a cytosolic ubiquitin ligase, and
PINK1, a mitochondrial kinase, are originally identified to be associated with Parkinson’s
disease (PD), and their mutations have been shown to cause the autosomal recessive
form of familial PD (Kitada et al., 1998; Valente et al., 2004). PD is a common
neurodegenerative disease characterized by the loss of dopaminergic (DA) neurons in
the substantia pars compacta. Loss of mitochondrial complex I activity has been
observed in the nigral neurons of human PD patients, indicating the link between PD and
mitochondrial dysfunction (Mounsey and Teismann, 2011).
1.2.1 Association of PINK1/Parkin with Mitochondrial Dysfunction
Loss of parkin function in Drosophila has been shown to cause apoptotic muscle
degeneration and spermatid individualization defects, resulting in flight and climbing
disabilities and male sterility in these flies. In addition, these tissue-specific phenotypes
are associated with abnormal mitochondrial structure (Greene et al., 2003). In parkin
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mutants, ultrastructural observations of mitochondria in indirect flight muscle during
development have shown swollen mitochondria with disintegrated cristae before the
muscle degeneration phenotype occurs. This suggests that mitochondrial disruption
underlies the cellular pathology observed in parkin mutants (Greene et al., 2003). As in
parkin mutants, lack of PINK1 function in Drosophila has also shown very similar tissuespecific phenotypes associated with abnormal mitochondrial morphology (Clark et al.,
2006; Park et al., 2006). Lack of both PINK1 and parkin also produces similar defects
with no further severity, suggesting that PINK1 and parkin are acting in a linear pathway.
Further genetic epistatic analyses have indicated that parkin is acting downstream of
PINK1 in this pathway, as parkin overexpression rescues the phenotypes in PINK1
mutants, but not vice-versa (Clark et al., 2006; Park et al., 2006). Loss of PINK1 function
in mice has shown mitochondrial functional defects in the striatum, suggesting the role of
PINK1 in maintaining mitochondrial function (Gautier et al., 2008). In addition, absence
of PINK1 causes an increased susceptibility of mitochondria to oxidative stress,
suggesting that PINK1 protects mitochondria against stress (Gautier et al., 2008). All
these studies in vivo clearly indicate the role of PINK1 and parkin in the maintenance of
mitochondrial functional integrity.
1.2.2 Model of PINK1/Parkin in Mitochondrial Turnover
PINK1, a mitochondrial kinase is present at very low levels on functional
mitochondria due to its constitutive degradation that is dependent on mitochondrial inner
membrane potential (Jin et al., 2010; Matsuda et al., 2010). However, PINK1
degradation is inhibited on depolarized mitochondria, and under these conditions the
protein accumulates and recruits cytosolic parkin to depolarized mitochondria (Matsuda
et al., 2010; Narendra et al., 2010; Vives-Bauza et al., 2010). Cytosolic parkin, an E3
ubiquitin ligase, has been found to translocate to depolarized mitochondria in cultured
cells treated with mitochondrial uncouplers, and only in the presence of PINK1
(Narendra et al., 2008; Vives-Bauza et al., 2010). This suggests that the loss of
mitochondrial membrane potential serves as a signal and PINK1 is required for parkin
localization to mitochondria. GFP-LC3-tagged autophagic vesicles have formed around
the depolarized mitochondria in the presence of parkin, suggesting the role of parkin in
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targeting depolarized mitochondria for mitophagy (Narendra et al., 2008; Vives-Bauza et
al., 2010).
Once targeted to damaged mitochondria, parkin has been proposed to
ubiquitinate the mitochondrial outer membrane proteins, which then mediate the
recruitment of ubiquitin-binding adaptor proteins including p62 and optineurin (Wei et al.,
2015). It has been shown that p62 is required for mitophagy (Geisler et al., 2010),
although other studies (Narendra et al., 2010; Okatsu et al., 2010) indicate that it has a
role in perinuclear clustering of mitochondria but not in mitophagy. Recently, optineurin
has been shown to mediate mitophagy process in the absence of p62 (Wong and
Holzbaur, 2014). In addition, optineurin has been shown to be recruited by parkin to the
damaged mitochondria prior to the formation of LC3 autophagic vesicles indicating the
role of optineurin as a receptor for mitophagy (Wong and Holzbaur, 2014).
All these reports support the role of PINK1 and parkin in tagging depolarized
mitochondria for mitophagy (Figure 1.3).

Figure 1.3 Model of PINK1 and Parkin in mitochondrial turnover. a) PINK1 is
degraded on healthy mitochondria. PINK1 retained on depolarized mitochondria (b),
recruits cytosolic parkin (c) that serves as a signal for mitochondrial turnover. Parkin
ubiquitinates mitochondrial outer membrane proteins (OMMs) which then recruit
optineurin as a mitophagy receptor, thereby tagging mitochondria for degradation (d).
(Figure is adapted and modified from Abeliovich, 2010; Fiskin and Dikic, 2013; Wei et
al., 2015).
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It is important to note that this model of PINK1/parkin in the selective turnover of
depolarized mitochondria has been proposed mainly based on studies in cell cultures
broadly treated with mitochondrial uncouplers. However, it is not known if PINK1-Parkin
pathway can selectively target depolarized mitochondria for turnover under normal
physiological conditions in vivo and in the nervous system.
1.2.3 Model of PINK1/Parkin in the Segregation of Depolarized Mitochondria
PINK1 and parkin have been shown to regulate mitochondrial morphology by
interacting with the mitochondrial fission and fusion proteins. Overexpression of fission
protein Drp1 or knockdown of fusion protein Opa1 has rescued the mitochondrial
structural defects in muscle tissue of Drosophila PINK1/parkin mutants. This implies that
PINK1/Parkin pathway regulates mitochondrial morphology either by promoting fission or
inhibiting fusion (Poole et al., 2008). Later studies have demonstrated the presence of
higher levels of fusion protein Mfn2, but not fission protein Drp1 in PINK1 and parkin
mutants suggesting that PINK1/Parkin pathway selectively mediates Mfn2 degradation
(Poole et al., 2010; Ziviani et al., 2010). Consistently, PINK1 and parkin have been
shown to cause Mfn1/2 degradation in human neuroblastoma cells on treatment with
mitochondrial uncouplers (Gegg et al., 2010). Thus, PINK1/Parkin pathway has been
proposed to have a role in the segregation of depolarized mitochondria by inhibiting their
fusion with healthy mitochondria (Poole et al., 2010). These fusion-incompetent
mitochondria, however, can undergo mitochondrial fission by Drp1 to generate small
fragmented mitochondria that can be easily engulfed by autophagic vesicles for turnover
(Poole et al., 2010). Recent studies in cultured cortical neurons treated with
mitochondrial depolarizing agents have shown that parkin translocated onto depolarized
mitochondria causes an increase in their retrograde flux for turnover in cell body (Cai et
al., 2012). Although mitochondrial turnover is often presumed to occur in the somatic
compartment, evidence from cultured neurons indicates that it can also occur in axons
(Maday et al., 2012). In addition to the role in mitochondrial turnover, PINK1/Parkin
pathway has been proposed to inhibit the axonal transport of mitochondria via the
degradation of Miro, a mitochondrion – kinesin linker protein (Wang et al., 2011; Liu et
al., 2012).
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However, the role of PINK1/Parkin pathway in mitochondrial turnover is not
known under normal physiological conditions in nervous system in vivo. In addition, we
understand very little about the changes that occur in the mitochondrial life cycle when
the mitochondrial turnover is disrupted particularly in neurons. To address the events of
mitochondrial life cycle that are presumed to be compartmentalized spatio-temporally in
neurons, I have chosen the Drosophila larval nervous system. This serves as an ideal
model in that it allows to perform live cell imaging at different regions of neurons
including the cell body, axon, and neuromuscular junctions (NMJs) (Shidara and
Hollenbeck, 2010; Devireddy et al., 2014). In addition, Drosophila is genetically tractable
and has well-established genetic procedures for generating gene deletion mutants (St
Johnston, 2013), and for manipulating gene expression via RNAi knockdown or
overexpression in specific tissues using UAS-Gal4 system (Brand and Perrimon, 1993).
Based on the proposed roles of PINK1 in mitochondrial quality control, I
hypothesized that the loss of PINK1 function will cause accumulation of senescent
mitochondria in the axon, defects in mitochondrial transport, and a significant shift in the
mitochondrial fusion-fission steady state. Here, I tested these hypotheses in vivo, using
quantitative observations of mitochondria in Drosophila nervous system with deletion
and overexpression of genes in the PINK1/Parkin pathway. Although I found diminished
mitochondrial membrane potential in PINK1 deletion, I did not observe the predicted
increase in mitochondrial density or length in axons. In addition, loss of PINK1 caused
more specific, essentially balanced defects in mitochondrial transport, without altering
the balance between stationary and moving mitochondria. These results circumscribe
the possible mechanisms of PINK1 action in the mitochondrial life cycle, and also raise
the possibility that mitochondrial turnover events that occur in cultured embryonic
neurons might be restricted to the cell body in vivo, in the intact nervous system.
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CHAPTER 2. MATERIALS AND METHODS

2.1 Materials
Scissors (Fine Science Tools- FST No. 15000-00 straight), two pairs of forceps
(FST, Dumont #5 Dumonstar No. 11295-00), Minutien insect pins (FST No. 26002-10),
glass slides (Rite-On microslides Cat no. 3050, size 25mm X 75mm) and coverslips (24
X 40 mm No.1, VWR Cat #16004-306), Sylgard plate (Sylgard 182 Silicone Elastomer
Kit), double sided permanent tape (Scotch Cat # 137DM-2 or 3M with 0.5 inch
thickness), VALAP (Vaseline, Lanolin and Paraffin wax in equal parts) heated to 750C,
paint brush with small brush head.
2.1.1 Chemicals: NaCl (Mallinckrodt chemicals; Cat No: 7581), KCl (Sigma; Cat No: P9541), MgCl 2 ·6H 2 O (Mallinckrodt chemicals; Cat No: 5958-04), NaHCO 3 (Sigma; Cat
No: S-6014), Isothionic acid sodium salt (Sigma; Cat No: 220078), BES (Sigma; Cat No:
B4554), Trehalose dehydrate (Sigma; Cat No: T9531), L-Alanine (Sigma; Cat No:
A7469), L-Arginine monohydrochloride (Sigma; Cat No: A6969), Glycine (Sigma; Cat
No: G-7126), L-Histidine (Sigma; Cat No: H6034), L-Methionine (Sigma; Cat No: M2893), L-Proline (Sigma; Cat No: P5607), L-Serine (Sigma; Cat No: S4311), L-Threonine
(Sigma; Cat No:T8441), L-Tyrosine (Sigma; Cat No: T8566), L-Valine (Sigma; Cat No:
V0513), CaCl 2 Dihydrate (Sigma; Cat No: C-3306), L-Glutamate monosodium salt
hydrate (Sigma; Cat No: G5889), tetramethylrhodamine methyl ester (TMRM, Life
Technologies, Molecular Probes; Cat No: T668), Dimethyl sulfoxide (DMSO-HybriMax;
sterile filtered 5X10ml vials; Sigma; Cat No: D2650).
2.1.2 Hemolymph-like solution (HL6 buffer):
Composition of HL6 Buffer: 23.7mM NaCl, 24.8mM KCl, 15mM MgCl 2 ·6H 2 O, 10mM
NaHCO 3 , 20mM Isothionic acid (Na+), 5mM BES, 80mM Trehalose, 5.7mM L-Alanine,
2mM L-Arginine HCl, 14.5mM Glycine, 11mM L-Histidine, 1.7mM L-Methionine, 13mM
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L-Proline, 2.3mM L-Serine, 2.5mM L-Threoine, 1.4mM L-Tyrosine, 1mM L-Valine,
0.6mM CaCl 2 Dihydrate and 4mM L-Glutamate monosodium salt hydrate (Macleod et
al., 2002, Louie et al., 2008).
HL6 buffer stock (1.25X) was prepared in sterile distilled water by dissolving all
the above components expect 4mM glutamate. The pH of the buffer was adjusted to 7.2,
followed by filter sterilization. This buffer stock and 1M glutamate stock were stored for
about 6-8 months at 4°C.
2.2 Drosophila Maintenance and Genetics
2.2.1 Maintenance of Drosophila Stocks:
Drosophila stocks were grown in vials with a standard yeast corn meal agar medium and
maintained in a fly room set to 250C temperature, 50-55% humidity, and 12 hour lightdark cycles. Genotypes of the fly stocks are as follows:
w1118
D42-Gal4>UAS-mitoGFP (III)
PINK1RV (I)
PINK1B9/FM7GFP (I); D42-Gal4>UAS-mitoGFP/TM6C (III)
PINK15/FM7GFP (I); D42-Gal4>UAS-mitoGFP/TM6C (III)
PINK19/FM7GFP (I); D42-Gal4>UAS-mitoGFP/TM6C (III)
Casper Pink1-Myc (III) (Referred as P(Pink1))
UAS-PINK1/CyOGFP (II); TM6B/MKRS (III)
UAS-Parkin/CyO (II)
UAS-NDI1 (II)
2.2.2 Crosses Set for Obtaining Larvae with Specific Genotypes: The above stocks were
used in specific crosses (Table 2.1) to obtain larvae of the following genotypes for use in
experiments.
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Table 2.1: Genotype Representation of Flies Used in Crosses

Crosses set up between

Genotype

Genotype of male
larvae used in

representation
Female virgins

in text and

Males

experiments

figures
Wild type

PINK1RV:

w1118

PINK1RV(I)

Control for

D42-Gal4>UAS-

D42-Gal4>UAS-

mitoGFP

mitoGFP/+

D42-Gal4>UAS-

PINK1RV/Y;D42>UAS-

mitoGFP

mitoGFP/+

w1118

PINK1B9/Y;D42>UAS-

PINK1B9
PINK1B9 mutant

PINK1B9/FM7GFP(I);D42
>UAS-mitoGFP(III)

PINK15 mutant

PINK15/FM7GFP(I);D42>

mitoGFP/+
w1118

UAS-mitoGFP(III)
PINK15/+:

PINK15/FM7GFP(I);D42>

Female

UAS-mitoGFP(III)

PINK15/Y;D42>UASmitoGFP/+

w1118

PINK15/+;D42>UASmitoGFP/+

heterozygous
(Female larvae)

control for
PINK15 mutant
B9;P(Pink1)

PINK1B9/FM7GFP(I);D42

P(Pink1)(III)

>UAS-mitoGFP(III)
PINK15;P(Pink1

PINK15/FM7GFP(I);D42>

)

UAS-mitoGFP(III)

B9;Parkin OE

PINK1B9/FM7GFP(I);D42
>UAS-mitoGFP(III)

PINK1B9/Y;D42>UASmitoGFP/P(Pink1)

P(Pink1)(III)

PINK15/Y;D42>UASmitoGFP/P(Pink1)

UAS-Parkin(II)

PINK1B9/Y;UASParkin/+;D42>UASmitoGFP/+
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PINK15;Parkin

PINK15/FM7GFP(I);D42>

OE

UAS-mitoGFP(III)

UAS-Parkin(II)

PINK15/Y;UASParkin/+;D42>UASmitoGFP/+

NDI1 OE

UAS-NDI1(II)

D42-Gal4>UAS-

UAS-

mitoGFP(III)

NDI1/+;D42>UASmitoGFP/+

B9;NDI1 OE

PINK1B9/FM7GFP(I);D42

UAS-NDI1(II)

>UAS-mitoGFP(III)

PINK1B9/Y;UASNDI1/+;D42>UASmitoGFP/+

PINK15;NDI1

PINK15/FM7GFP(I);D42>

OE

UAS-mitoGFP(III)

UAS-NDI1(II)

PINK15/Y;UASNDI1/+;D42>UASmitoGFP/+

PINK1B9 mutant

PINK1B9/FM7GFP(I);D42

Cross was not

PINK1B9/Y;D42-

>UAS-mitoGFP(III)

required; Larvae

Gal4>UAS-mitoGFP

were collected
from stock
PINK15 mutant

PINK15/FM7GFP(I);D42>

Cross was not

PINK15/Y;D42-

UAS-mitoGFP(III)

required; Larvae

Gal4>UAS-mitoGFP

were collected
from stock
PINK19 mutant

PINK19/FM7GFP(I);D42>

Cross was not

PINK19/Y;D42-

UAS-mitoGFP(III)

required; Larvae

Gal4>UAS-mitoGFP

were collected
from stock
PINK19;P(Pink1

PINK19/FM7GFP(I);D42>

)

UAS-mitoGFP(III)

P(Pink1)(III)

PINK15/Y;D42>UASmitoGFP/P(Pink1)
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PINK1 OE(1)

UAS-

+/+(II); D42>UAS-

UAS-

mitoGFP(III)

PINK1/CyoGFP( PINK1/+;D42>UASII);D42>UAS-

mitoGFP

mitoGFP(III)
PINK1 OE(2)

UAS-

Cross was not

UAS-PINK1;D42>UAS-

PINK1/CyoGFP(II);D42>

required; Larvae

mitoGFP

UAS-mitoGFP/TM6C(III)

were collected
from stock

Parkin OE(1)

+/+(II); D42>UAS-

UAS-

UAS-

mitoGFP(III)

Parkin/CyoGFP(

Parkin/+;D42>UAS-

II);D42>UAS-

mitoGFP

mitoGFP/TM6C(
III)

2.2.3 Selection of Male Drosophila Larvae for Experiments:
The PINK1 gene is present on the X chromosome in Drosophila and all PINK1 deletion
mutants (PINK1B9, PINK15, and PINK19) are sterile both as homozygous females and
hemizygous males. However, PINK1 mutant stocks are maintained using a balancer
chromosome and it is possible to collect mutant males. Thus, male larvae were chosen
for all the genotypes except for PINK15/+.
In Drosophila larvae, gonads are present in the fifth abdominal segment of the
posterior part of the body. The size of gonad is larger in males than females, which
appears as a clear round halo structure in males compared to small spot like structure in
females. Thus male larvae are identified easily by observing the halo structure through
the transparent larval body wall prior to dissection (Demerec, 1950).
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2.3 Drosophila Larval Prep for Live Cell Confocal Imaging (Larval Prep)
Prior to larval dissection, 1X HL6 buffer with 4mM glutamate was constituted
from HL6 buffer stock and 1M glutamate stock, and brought to room temperature before
applying to larvae. The glass slide, which serves as an imaging chamber, was prepared
by attaching two strips of double sided tape cut lengthwise as spacers, so as to match
the length of the coverslip (Devireddy et al., 2014).
2.3.1 Dissection procedure:
The whole procedure of dissection is completed in five minutes. First, a crawling late
third instar larva is washed in distilled water with a paint brush to remove any food
particles, and is then placed on a slygard plate with the dorsal surface facing upwards,
viewing two long tracheal tubes running along the length of the larval body. The larva is
then pinned with insect pins, first at the posterior end followed by the anterior end
(Figure 2.1 Aa). A small incision is made at the posterior end of the larva with fine
scissors and then cut longitudinally from posterior to anterior end by just holding the
larval body wall (Figure 2.1 Ab,c). Immediately, 400µl of HL6 buffer is added to the larva
and internal tissues such as tracheal tubes, intestines, fat bodies and salivary glands are
gently removed using forceps, leaving the ventral ganglion and segmental nerves intact.
The buffer with separated internal tissues is quickly removed with a kimwipe and
replaced with fresh buffer, to clearly visualize the brain lobes and segmental nerves
attached to the larval body wall (Figure 2.1 Ad). In order to make the body wall flat, small
lateral cuts perpendicular to the longitudinal cut are made on both sides at posterior and
anterior ends (Figure 2.1 Ae,f). The pins are then removed first at the anterior end by
gently holding the mouth hooks with forceps, and then at the posterior end (Figure 2.1
Ag).
2.3.2 Preparation of Dissected Larva for Imaging:
After removing the insect pins, the dissected larva is moved onto the glass slide with
double sided tape, by just holding the spiracles at the posterior end. While moving the
larva onto glass slide, care must be taken to transfer only a few microliters (µl) of buffer
along with larva, just enough that the larval body wall flaps can be opened with ease,
and this also helps the larval preparation not to dry out until the next step. Lateral body
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wall flaps are opened starting from the posterior to the anterior end (Figure 2.1 Ah) and
the ventral ganglion is made to stretch out by holding the mouth hooks. A coverslip is
then carefully placed on the larval prep and ~150µl HL6 buffer is added from the
posterior end towards ventral ganglion region and sealed with VALAP on both sides to
form an imaging chamber. While adding the HL6 buffer, the dissected larva stretches out
longitudinally revealing all segmental nerves ending in corresponding abdominal
segments A1-A8 (Figure 2.1 Ai, j).

Figure 2.1 Procedural steps of Drosophila larval dissection. a) Larva is immobilized
on slygard plate by inserting insect pins at the anterior (A) and posterior (P) ends. b) A
small opening is made at the posterior end using the fine scissors. c) From this small
opening, larval body wall is cut longitudinally towards the anterior end. d) After the
removal of internal tissues, buffer is added to reveal the ventral ganglion and segmental
nerves. e, f) Small lateral cuts are made at the posterior end (e) followed by anterior end
(f) to open up the folded larval body wall. g) This image represents the properly
dissected larva after the removal of insect pins. h) The dissected larva is transferred
onto glass slide and folded body wall is opened gently beginning at the posterior end as
indicated by arrow and then at the anterior end. i, j) Representative bright-field image (i)
and fluorescent image (j) of the dissected larva with completely stretched out segmental
nerves (SNs) suitable for imaging at defined positions (Figure is adapted and modified
from Devireddy et al., 2014).
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A Drosophila line expressing mitochondrial targeted GFP (mitoGFP) specifically in motor
neurons was used in this study (Figure 2.2).

Figure 2.2: MitoGFP expression in Drosophila motor neurons. a) Image showing the
Drosophila larval nervous system (a) expressing mitoGFP in motor neurons with cell
bodies (CBs) in ventral ganglion (VG) (b), segmental nerve (SN) axons (c), and
neuromuscular junctions (NMJs) (d). (Figure is adapted and modified from Devireddy et
al., 2014).
2.4 Analysis of Mitochondrial Motility in Segmental Nerves (SNs)
2.4.1 Acquisition of Time Lapse Images Using Confocal Microscopy
Time lapse images of mitoGFP were acquired in the middle (A4) abdominal region of the
longest SN in the larva (Figure 2.2). All imaging was performed with a Nikon C-1 laser
scanning confocal microscope (Nikon Eclipse 90i) using EZ-C1 software. Time lapse
images were acquired using a 60X oil-immersion objective and 2.5X zoom at 1024 pixel

27
resolution and at 1frame/second for five minutes with a 488nm laser (5%; 150mW laser
power) and a 30μm pinhole. The whole imaging process was then completed within 25
minutes to ensure normal physiological conditions of the live nervous system.
2.4.2 Tracking of Anterograde and Retrograde Mitochondria Using ImageJ
In Drosophila SNs, anterograde and retrograde mitochondria can be easily distinguished
because they move preferentially in the primary direction for the majority of the time, with
only a small fraction of time spent moving in reverse runs or in pauses. In addition,
stationary mitochondria remain at the same position during the entire imaging period in
Drosophila larval SNs. All three types of mitochondria can be seen in kymographs
prepared from the time lapse images, in Nikon NIS-Elements software by using the
“create kymograph by line” option in Image/ND processing. The numbers of
mitochondria that cross the line drawn in the center of the image per unit time were
counted using the “cell counter” plugin in ImageJ. This number represents the
mitochondrial flux per unit time.
For quantifying the other mitochondrial motility parameters such as duty cycles
(% time mitochondria spend in their primary direction runs, reverse runs, and pauses),
and run velocities, individual mitochondria were tracked using the manual tracking plugin
of ImageJ (Pilling et al., 2006, Shidara and Hollenbeck, 2010, Devireddy et al., 2014). To
correct for any larval movements causing drift, stationary mitochondria were tracked for
the entire length of the movie and x-y coordinates were saved for all frames. A minimum
number of five anterograde and five retrograde mitochondria were tracked for ≥ 60
seconds and corrected for drift using x-y coordinates of stationary mitochondrion,
corresponding to time frames of tracked moving mitochondria. The x-y coordinates of
tracked mitochondria were saved into an excel sheet and the distance moved by
mitochondria from frame to frame was tabulated.
Criteria for mitochondrial motility analysis:
a) Movements with average velocities >0.08 µm/sec or <-0.08 µm/sec for at least
three consecutive frames were selected as anterograde and retrograde runs
respectively. A run could be preceded and ended by pauses or by reverse runs
(1 pixel = 0.08 µm, a minimum measurable distance).
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b) Periods with average velocities between 0.08 µm/sec and -0.08 µm/sec for at
least two consecutive frames were considered as pauses.
After determining the runs and pauses, the run velocities and duty cycles were
quantified. The velocity of a mitochondrion was determined by taking the average of all
run velocities for that particular mitochondrion during the observation period. Duty cycles
were calculated based on the percentage of time mitochondria spent moving in the
primary direction, reverse runs and in pauses.
2.4.3 Determination of Stationary, Anterograde, Retrograde and Oscillatory Mitochondria
To quantify the percentage of moving mitochondria in SNs, time lapse images were
captured at 1 frame / 2 seconds for two minutes (same imaging settings as above).
Here, images were acquired at 2 second time interval to allow for 2 frame kalman
averaging, to increase the signal to noise ratio. Mitochondria present in the first image of
the time lapse sequence were only considered when counting the stationary and moving
mitochondria, due to the varied number of moving mitochondria entering the field of view
over time. Mitochondria were categorized as anterograde, retrograde, stationary
(remaining at the same position during the imaging period), or oscillating (moving back
and forth with an amplitude of ≤ 5 μm without significant net displacement). These
different categories of mitochondria were counted using the “cell counter” plugin in
ImageJ and the cell counters were saved with numbers indicating the different
categories, for measuring mitochondrial lengths (Refer Section 2.6.1).
2.4.4 Determination of Mitochondrial Density in Motor Axons
The first image of the above time lapse sequence acquired at 1 frame / 2 seconds was
selected to determine the mitochondrial density in motor axons. The image was
thresholded, and then binarized using ImageJ. On these binarized images, the number
of mitochondrial pixels per length of segmental nerve was obtained, to represent
mitochondrial density in motor axons.
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2.5 Determination of Mitochondrial Inner Membrane Potential (IMP)
2.5.1 Treatment of Larval Prep with TMRM
Preparation of TMRM stock and working solutions: 20mM TMRM stock (200µl) was
prepared by dissolving TMRM powder in sterile filtered DMSO, by vortexing for a minute.
Then 5µl stock aliquots were made and stored in -800C freezer for use within 6-8
months. Before performing the TMRM experiment, 20mM stock aliquot was thawed to
prepare fresh 20µM TMRM (1ml) in DMSO. From this 20µM TMRM, 200nM and 50nM
TMRM working solutions were prepared in HL6 buffer for treatment of larval prep. The
dissected larval prep was treated with 200nM TMRM working solution for 30 minutes in a
glass dish. After 30 minute incubation, larval prep was gently moved without washing,
onto glass slide and covered with coverslip. Then 50nM TMRM solution is added to the
larval prep for imaging.
2.5.2 Image acquisition in thin neurons and neuromuscular junctions
Thin neurons, adjacent to SNs in middle (A4) abdominal segment of the larva, were
chosen for imaging. MitoGFP and TMRM imaging in thin axons, was performed with a
488nm laser (2-4%) and a 561nm laser (1-2%) respectively, using sequential scan
(Nikon Eclipse 90i). Images of neuromuscular junctions 6/7 (NMJs 6/7) in A4 segment
were acquired sequentially with 488nm (5%) and 561nm (<5%) lasers for mitoGFP and
TMRM respectively. 561nm laser power was adjusted to avoid acquiring saturated pixels
since the images were used for quantification. Both thin neuronal and NMJs 6/7 images
were acquired using a 60X oil-immersion objective and 2.5X zoom at 512 pixel
resolution, with the Nikon C-1 laser scanning confocal microscope using EZ-C1
software. The images were taken within 15 minutes after the slide was prepared for
imaging. Only NMJs 6/7 were imaged but not SNs and motor neuron cell bodies in
ventral ganglion as the TMRM dye could not penetrate the glial sheath covering SNs and
ventral ganglion.
2.5.3 Quantitative assessment of TMRM fluorescent intensities
The TMRM images of axons or NMJs were thresholded to isolate the mitochondrial
pixels. Then the mitochondrial fluorescence intensities (F m ) were measured using
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“analyze particles” option after selecting for mean gray value option in “analyze/set
measurements” in ImageJ. Adjacent cytoplasmic fluorescence intensities (F c ) were
determined using hand drawn regions (0.4-0.5 µm2 area) in the axons, next to
mitochondria. The ratio of mitochondrial to cytoplasmic fluorescence (F m /F c ) was used
as a logarithmic measure of mitochondrial inner membrane potential (IMP or Δψ m ) in
axons (Verburg and Hollenbeck, 2008, Shidara and Hollenbeck, 2010). As the
cytoplasmic regions cannot be clearly defined near NMJs, the mean mitochondrial
intensities (F m ) quantified from thresholded TMRM images were used to represent the
IMP or Δψ m at NMJs (Shidara and Hollenbeck, 2010).
2.6 Determination of mitochondrial morphology in motor neurons
2.6.1 Semi-automated method for mitochondrial length measurements in motor axons
Time lapse images originally acquired for determining the percent moving mitochondria,
and their cell counters saved for different categories of mitochondria, were used to
determine mitochondrial lengths in motor axons. A time lapse image sequence was
thresholded, binarized and the “feret’s diameter” option was selected in the
“ImageJ/analyze/set measurements” menu to measure mitochondrial lengths. In
addition, “watershed” function was used to separate the adjoined stationary mitochondria
whose edges were not distinct enough, before measuring their lengths.
2.6.2 Acquisition of z-stack of motor cell body images in ventral ganglion
Confocal z-stack of motor neuron cell bodies present in ventral ganglion were acquired
with slice thickness of 0.15µm, using a 488nm (1.8%) laser and 60X oil immersion Nikon
objective at 2.5X zoom. The stacks were aligned with the “ImageJ/stackreg” plugin
(Thevenaz et al., 1998), using the middle slice as an anchor, to eliminate the effects of
drift.
2.6.3 2D image quantitation of mitochondrial size in motor cell bodies (CBs)
The size of the large round mitochondria in CBs was measured by selecting the “area”
option in “ImageJ/analyze/set measurements” menu and then drawing the “polyline
selection” around mitochondria in a z-slice where they were in sharp focus. Then the cell
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bodies with large, round mitochondria of sizes >2µm2 were counted and represented as
%CBs with large round mitochondria.
2.6.4 Quantitative 3D image analysis of mitochondrial volume in motor cell bodies
For determining the mitochondrial volume in CBs, the intensity threshold was adjusted
manually to include all z-slices of cell bodies. Then, mitochondrial volume was
determined in CBs using “3D object counter” (Bolte and Cordelieres, 2006) and “3D ROI
manager” (Ollion et al., 2013) plugins in ImageJ. 3D object counter was used to
determine if all mitochondrial pixels in cell body were taken for volumetric
measurements. 3D ROI manager was used to obtain the values of mitochondrial volume
in the cell bodies after running 3D object counter.
2.7 Statistical tests
The number of larvae analyzed in all experiments ranged from 8-11 and was indicated in
graphs and error bars represent means ± SEM. All statistical analysis was performed
using “GraphPad Prism 5”. For normally distributed data, one way ANOVA with
Bonferroni’s post test was used. For non-normally distributed data, the non-parametric
Kruskal-Wallis test followed by Dunn’s post test was used. All statistical comparisons
were performed between wild type control vs. PINK1 mutants, and mutants vs. mutants
with PINK1 genomic level expression or parkin or NDI1 overexpression and were
indicated in figures or figure legends. For the analysis of mitochondrial length
distributions, a non-parametric two sample Kolmogorov-Smirnov (KS) test was
performed (Siegel and Castellan, 1988).
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CHAPTER 3. RESULTS

3.1 Mitochondrial Inner Membrane Potential (IMP or ΔΨ m ) is Diminished in the
Absence of PINK1
Loss of PINK1 function has been shown to cause mitochondrial structural defects
in Drosophila flight muscle (Clark et al., 2006; Park et al., 2006) and functional defects in
mouse striatum (Gautier et al., 2008). These studies indicate that PINK1 is required for
the maintenance of mitochondrial integrity. In addition, PINK1 has been shown to
accumulate on depolarized mitochondria in cell cultures treated with mitochondrial
uncouplers (Jin et al., 2010; Matsuda et al., 2010; Narendra et al., 2010). Recently,
PINK1 has been shown to be required for the initiation and the formation of autophagic
vesicles around damaged mitochondria in cultured neurons treated with mitochondrial
damaging agents (Ashrafi et al., 2014). Based on these cell culture studies, PINK1 has
been proposed to have a role in targeting damaged mitochondria for turnover. However,
the role of PINK1 in mitochondrial turnover is not known in nervous system in vivo under
normal physiological conditions. Here, I tested the hypothesis that the loss of PINK1
function will cause the accumulation of senescent mitochondria with diminished
mitochondrial inner membrane potential (IMP or ΔΨ m ) by inhibiting turnover in axons.
To test this hypothesis in vivo, I first assessed the IMP of mitochondria in
neurons of the intact Drosophila nervous system. To a filleted larval preparation (Pilling
et al., 2006; Shidara and Hollenbeck, 2010; Devireddy et al., 2014), I applied TMRM, a
lipophilic cationic fluorescent dye, which partitions between the cytoplasm and the
mitochondrial matrix based on the magnitude of the IMP (Figure 3.1A,C) (Scaduto and
Grotyohann, 1999; Verburg and Hollenbeck, 2008). I quantified the ratio of mitochondrial
to cytoplasmic fluorescence intensities (F m /F c ), which is related logarithmically to IMP in
axons (Verburg and Hollenbeck, 2008; Shidara and Hollenbeck, 2010). I observed ~3439% reduction in the mean F m /F c values in motor axons and ~16-38% decrease in mean
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F m values in NMJs of PINK1 mutants (PINK1B9 or PINK15) compared with control, as
expected (Figure 3.1 B,D). This deficit is partially rescued in NMJs of PINK1 mutants by
expressing physiological levels of PINK1 from a genomic promoter (Clark et al., 2006)
(Figure 3.1 B,D) suggesting the role of PINK1 in the maintenance of mitochondrial IMP.
Because the ubiquitin ligase parkin has been shown to act downstream in the
PINK1 mitochondrial maintenance pathway (Clark et al., 2006; Park et al., 2006; Poole
et al., 2008), I also assessed the IMP in PINK1 mutants with parkin overexpression and
observed significant rescue of IMP in NMJs (Figure 3.1D) and a trend toward rescue in
PINK15 mutant axons (Figure 3.1B). The restoration of mitochondrial IMP in PINK1
mutants by parkin overexpression suggests that parkin is acting downstream of PINK1 in
the maintenance of mitochondrial IMP. In PINK1 mutants, either expressing PINK1 at
genomic levels or overexpressing parkin rescued the mitochondrial IMP in NMJs, but did
not in axons, suggesting that the roles of PINK1 and parkin in maintaining mitochondrial
function differ by region, perhaps in relation to specific bioenergetic demands of different
compartments (Hollenbeck, 2005; Hollenbeck and Saxton, 2005).
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Figure 3.1 Neurons of PINK1 mutants show reduced mitochondrial IMP or ΔΨ m .
A, C, TMRM staining of mitochondria (red) reveals the mitochondrial membrane
potential (ΔΨ m ), whereas mitoGFP (green) is used to identify mitochondria in axons (A)
and NMJs (C) of Drosophila larval motor neurons in segmental nerves. Merge (yellow)
shows the colocalization of mitoGFP- and TMRM-stained mitochondria. These images
show PINK1RV control larvae. Scale bar, 5µm. Mean F m /F c intensity ratios of TMRM in
axons (B) and mean F m intensities of TMRM in NMJs (D) are quantified for PINK1RV
control, PINK1B9, B9;P(Pink1) (genomic rescue), and B9;Parkin OE and for PINK15/+
control, PINK15, PINK15;P(Pink1) (genomic rescue), and PINK15;Parkin OE. Compared
with control larvae, PINK1 mutants show a decrease in mean TMRM intensities, which is
rescued significantly in NMJs by expression of P(Pink1) and parkin overexpression (OE)
but improved only modestly in PINK15 mutant axons. Error bars indicate SEM; number of
larvae is represented on graph bars. Ten to 20 mitochondria were quantified per larva.
**p < 0.01, ***p < 0.001 (one-way ANOVA with Bonferroni’s post-test); ns, nonsignificant
differences.
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3.2 Mitochondrial axonal transport is impaired in the absence of PINK1
Because most mitochondrial turnover in neurons is thought to occur in the cell
body (Cai et al., 2012; Saxton and Hollenbeck, 2012), another prediction of PINK1
involvement in mitochondrial turnover is that reduced PINK1 function should cause the
accumulation of senescent mitochondria in the axon, through a reduction in their
retrograde retrieval and turnover. To examine this, I quantified mitochondrial axonal
transport in motor axons of middle segmental nerves (A4) of Drosophila larvae by
tracking individual mitochondria on the time lapse images (Shidara and Hollenbeck,
2010; Devireddy et al., 2014).
3.2.1 Loss of PINK1 Function causes a Reduction in both Anterograde and Retrograde
Mitochondrial Flux
In axons of segmental nerves, anterograde and retrograde populations of
mitochondria are clearly distinguished from each other by their preferential movement in
the dominant direction, with a smaller fraction of their time spent pausing, and a very
small fraction spent reversing direction; this can be seen in kymographs (Figure 3.2A). A
detailed quantification of motility (Figure 3.2B,C) showed that mitochondrial flux was
actually reduced in both the anterograde and retrograde directions in PINK1 mutants
compared with wild-type, and this was rescued significantly by the expression of PINK1
by a genomic promoter and partially by overexpression of parkin (Figure 3.2B,C).
3.2.2 Anterograde Mitochondria show Reduced Duty Cycles and Retrograde
Mitochondria show Reduced Velocities
To understand the specific changes in mitochondrial motility behavior that
caused reduced flux, I quantified the duty cycles and velocities of the moving
mitochondrial population in axons of wild-type and PINK1 mutants. In wild-type,
anterograde mitochondria spent ~70% time in anterograde runs, ~29% in pauses, and
~1% in retrograde runs. In the absence of PINK1, anterograde mitochondria showed a
significant reduction in percentage of time in anterograde runs (55%–60%), resulting in
an increase in percentage of time in pauses (38%–44%); however, there was no change
in retrograde runs (~1%) (Figure 3.2D). These defects in duty cycles of anterograde
mitochondria were ameliorated by expressing PINK1 with a genomic promoter or by
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parkin overexpression. However, duty cycles of retrograde mitochondria were only
modestly affected in PINK1 mutants compared with wild-type (Figure 3.2E). In addition,
the anterograde velocities were not affected (Figure 3.2F), but retrograde velocities were
reduced by the loss of PINK1, compared with wild-type (Figure 3.2G). Thus, the
reduction in anterograde flux observed in the absence of PINK1 results in large part from
reduced anterograde duty cycles, whereas the small reduction in retrograde flux can be
explained by reduced velocities (Table 3.1). The net loss of retrograde retrieval predicted
by the proposed PINK1 role in mitochondrial turnover is not observed here.
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Figure 3.2 PINK1 mutants show bidirectional mitochondrial motility changes with
reduced flux and reduced anterograde duty cycles. A, Kymographs of axonal
mitochondrial transport in segmental nerves of wild-type, PINK1B9, B9;P(Pink1) (genomic
rescue), and B9;Parkin OE, displaying 5 min of movement; anterograde movement is
toward the right. Vertical lines indicate stationary mitochondria. Scale bar, 10µm. B, C,
PINK1 mutants show reduced flux in both anterograde (B) and retrograde (C) directions.
This is rescued by expression of P(Pink1) and is partially rescued by parkin
overexpression. D, E, PINK1 mutants show reduced duty cycles for anterograde
mitochondria, with more time spent in pauses and less time moving in their primary
anterograde direction (D). However, duty cycles of retrograde mitochondria are
unchanged by loss of PINK1 (E). F, G, Mean run velocities of retrograde (G), but not
anterograde (F), mitochondria are reduced in the absence of PINK1. The number of
larvae analyzed for different genotypes is indicated on each bar. Each larval mean was
calculated by averaging the values of at least five mitochondria for each direction, and
tests were performed on the means of the larval means. Error bars indicate SEM. Oneway ANOVA with Bonferroni’s post-test was used for normally distributed data. Kruskal–
Wallis with Dunn’s post-test was used for non-normally distributed data. *p < 0.05, **p <
0.01, ***p < 0.001; ns, non-significant differences.
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3.2.3 Balance between Stationary and Moving Mitochondria remains unaltered in the
Absence of PINK1 or in PINK1 Overexpression Conditions
Another way in which mitochondrial flux in the axon could be modulated by the
PINK1 pathway would involve the recruitment between persistently stationary and motile
populations (Saxton and Hollenbeck, 2012; Devireddy et al., 2014). Indeed, it has
recently been proposed that PINK1 stops the movement of depolarized mitochondria by
stimulating degradation of Miro, a kinesin-mitochondria adaptor protein (Wang et al.,
2011; Liu et al., 2012).
Thus, I analyzed the total mitochondrial population in motor axons of SNs to
determine whether the loss or overexpression of PINK1 altered the fractions of moving
and persistently stationary mitochondria. In wild-type nerves, the majority of axonal
mitochondria are stationary (72.9 ± 1.2%; mean ± SEM); and of the 26% that are
moving, 18.8 ± 1.3% move anterogradely and 7.4 ± 0.9% move retrogradely (Figure
3.3A,B). In PINK1 mutants, by comparison, I did not observe any significant change in
distribution between the stationary or moving populations (Figure 3.3B; Table 3.1).
Furthermore, overexpression of PINK1 or parkin in a single copy had modest or no
effects on either stationary or moving mitochondrial numbers, whereas overexpression
of PINK1 in two copies actually caused an increase in the retrograde population only
(Figure 3.3C). These data suggest that the balance between the persistently moving and
stationary mitochondrial populations is virtually unaffected by PINK1 levels, even though
mitochondrial motility behavior is affected by PINK1 loss. I did observe a significant
increase in the small fraction of oscillating mitochondria (from ~1% to 4.3% of total
mitochondria) in motor axons when PINK1 was overexpressed (Figure 3.3A,D). A similar
motility phenotype has been observed previously in regions of vertebrate axons focally
stimulated with nerve growth factor (NGF); there, it was attributed to the initiation of
static docking interactions between mitochondria and the actin cytoskeleton in response
to signaling (Chada and Hollenbeck, 2003; Chada and Hollenbeck, 2004).
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Figure 3.3 Balance of moving and stationary mitochondria in PINK1 loss of
function and overexpression conditions. A, Kymographs of axonal mitochondrial
motility in A4 segmental nerves of wild-type, PINK15, PINK1B9, PINK1 OE(1), PINK1
OE(2), and Parkin OE(1), displaying 2 min of movement; anterograde movement is
toward the right. Vertical lines indicate stationary mitochondria. Arrows indicate the
movement of anterograde mitochondria (green), retrograde mitochondria (red) in PINK1
mutants, and oscillatory movements of mitochondria (brown) in PINK1 OE and parkin
OE. Scale bar, 5µm. B, In wild-type segmental nerves, ~72% of mitochondria are
stationary, with ~20% moving anterogradely and ~10% moving retrogradely. None of the
PINK1 mutants showed a significant difference in percentage of either stationary or
moving (anterograde, retrograde) mitochondria. C, Single-copy overexpression of PINK1
OE(1) or parkin OE(1) also produces no change in the fraction of stationary
mitochondria, whereas two-copy overexpression of PINK1 OE(2) actually increases the
percentage of retrogradely moving mitochondria. D, Oscillating mitochondria, observed
rarely in wild-type (<1%), increase significantly to ~3-4% in PINK1 OE(1) and PINK1
OE(2). Number of larvae analyzed is indicated on each bar. Error bars indicate SEM. **p
< 0.01, ***p < 0.001 (one-way ANOVA with Bonferroni’s post-test); ns, nonsignificant
differences compared with wild-type (B–D) and PINK1;P(Pink1) compared with PINK1
mutants (D).
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Table 3.1 Parameters of Mitochondrial Axonal Transport in Drosophila Motor
Axons
Wild-type

PINK1B9

PINK15

Anterograde Flux

3 ± 1.2

1.8 ± 0.7 ↓ *

1.8 ± 0.5 ↓ *

Retrograde Flux

2.4 ± 0.7

0.8 ± 0.5 ↓ *

1.5 ± 0.7 ↓

%time in Anterograde direction

71 ± 2.5

61 ± 6.3 ↓

56 ± 3.4 ↓ *

%time in Pauses

29 ± 2.6

38 ± 2.1 ↑ *

43 ± 3.0 ↑ *

%time in Retrograde direction

63 ± 3.7

54 ± 3.5

55 ± 3.6

%time in Pauses

33 ± 2.5

41 ± 3.4

41 ± 3.8

0.29 ±

0.27 ± 0.02

0.27 ± 0.004

0.49 ±

0.35 ± 0.02 ↓

0.39 ± 0.008

0.05

*

↓

Anterograde Mitochondria

19 ± 1.3

15 ± 1.3

20 ± 1.1

Retrograde Mitochondria

7.4 ± 0.9

7 ± 0.8

6 ± 0.8

S.No Mitochondrial Parameters
1

2

Flux (Number moving per minute)

Duty cycles (%Time mitochondria
spent)
Anterograde Mitochondria

Retrograde Mitochondria

3

Velocities (µm/sec)
Anterograde Mitochondria

0.03
Retrograde Mitochondria

4

Percent Moving Mitochondria

Table 3.1 Parameters of Mitochondrial Axonal Transport in Drosophila Motor
Axons
In PINK1 mutants, reduced flux is caused due to changes in motility behavior of
mitochondria: anterograde flux due to reduced anterograde duty cycles and retrograde
flux due to reduced retrograde velocities. In addition, the reduction in flux is not caused
due to changes in percent moving mitochondria as loss of PINK1 function do not affect
the percent moving mitochondria in motor axons. Values represent mean ± SEM;
affected parameters are indicated in red font with upward arrows (↑) for an increase and
downward arrows (↓) for decrease; asterisks (*) indicate the statistically significant
differences.
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3.3 Mitochondrial Morphology in Motor Axons in the Absence of PINK1 or in
PINK1 Over-expression conditions
Because PINK1 has been proposed to inhibit the fusion of damaged with healthy
mitochondria via degradation of the fusion protein dMfn (Poole et al., 2010; Ziviani et al.,
2010), another prediction of the PINK1/Parkin model of mitochondrial quality control is
that PINK1 mutants should show a shift of the fission-fusion balance toward fusion and
thus accumulate longer mitochondria.
3.3.1 Mitochondrial Lengths are unchanged in the absence of PINK1
In motor axons of wild-type larva (Figure 3.4Ai), I observed that stationary
mitochondria (1.3 ± 0.04 µm; mean ± SEM) were not significantly longer than moving
mitochondria (anterograde, 1.21 ± 0.04 µm; retrograde, 1.24 ± 0.09 µm). When
compared to wild-type, PINK1 mutants showed no significant difference in the mean
lengths of either their stationary or moving mitochondria (Figure 3.4Aii, B–D). Deficient
inhibition of fusion could also result in a small outlying population of longer organelles
not detectable as a difference in means, so I compared the frequency distribution of
mitochondrial lengths. Despite the appearance of a slight skew toward longer categories
in PINK1 mutants, I found no statistically significant difference in the length distribution of
stationary mitochondria (Figure 3.4E) (ns, nonparametric two-sample KS test). Thus,
loss of PINK1 function did not result in detectable accumulation of longer mitochondria in
motor axons.
3.3.2 Mitochondria become Smaller in PINK1 Overexpression Condition
Overexpression of PINK1 (Figure 3.4Aiii) significantly reduced the mean lengths
of stationary mitochondria (1.11 ± 0.02 µm) (Figure 3.4B), without affecting the mean
lengths of moving mitochondria (Figure 3.4C,D). Analysis of the stationary length
distribution also showed more small mitochondria in PINK1 overexpression compared
with wild-type (Figure 3.4E) (p < 0.001, nonparametric two-sample KS test). These
results suggest that overexpression of PINK1, but not its loss, affected mitochondrial
morphology in motor axons.
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Figure 3.4 PINK1 loss does not shift fission–fusion balance toward longer axonal
mitochondria.
(A) Mitochondria in the axons of wild-type (i), PINK1B9 mutant (ii), and PINK1 OE(1) (iii).
Scale bar, 5µm. Mean lengths of stationary (B), anterograde (C), and retrograde (D)
mitochondria are determined for wild-type, PINK1 mutants, and PINK1 OE(1). Only
PINK1 OE(1) produces a change, and this is a decrease in mean lengths of stationary
mitochondria (B). (E) Frequency distribution of stationary mitochondrial lengths (µm) was
analyzed for wild-type, PINK1B9, and PINK1 OE(1). (B-D) Number of larvae analyzed is
shown on each bar. Error bars indicate SEM. *p < 0.05 (nonparametric Kruskal–Wallis
test followed by Dunn’s post-test); ns, nonsignificant values compared with wild-type.
Nonparametric two-sample KS test for frequency distribution (E), p < 0.001 for wild-type
versus PINK1 OE(1) and nonsignificant for wild-type versus PINK1B9.

43
3.4 Mitochondrial Morphology in Motor Cell Bodies (CBs) in PINK1 Loss of
Function
3.4.1 Large Discrete Rounded Mitochondria in CBs in the absence of PINK1
Even though mitochondrial lengths are unaffected in motor axons, mitochondrial
morphology in motor CBs was indeed affected by PINK1 loss. Whereas mitochondria
were organized as a filamentous reticulum in motor CBs in the ventral ganglion of wildtype larvae (Figure 3.5Ai,Avi), PINK1 mutants show a subset of much larger, rounder,
discrete mitochondria (Figure 3.5Aii,Avii, arrows). I quantified the percentage of CBs with
these abnormally large mitochondria (defined as having an area of >2 µm2 in 2D
projection) and found that the loss of PINK1 caused the formation of these abnormal
mitochondria in ~60% of the CBs observed (Figure 3.5B) compared with only 8% in
control wild-type larvae. Normal mitochondrial morphology was significantly restored by
the expression of genomic levels of PINK1 or by the overexpression of parkin (Figure
3.5B). These data suggest that mitochondrial morphology is altered in CBs in the
absence of PINK1 function, probably due to defects in the fusion–fission steady state. It
does remain possible that some of the large mitochondrial structures actually result from
the clustering of many small, fragmented mitochondria that are not resolved individually
by our methods. The rescue of mitochondrial defects in PINK1 loss-of-function mutants
by parkin overexpression suggests that in the cell bodies, parkin is indeed acting
downstream of PINK1 in a regulatory pathway, as indicated by genetic studies (Clark et
al., 2006; Park et al., 2006).
3.4.2 Overexpression of Yeast Complex I NDI1 Recovers the Mitochondrial Morphology
in CBs
The abnormal mitochondrial morphology in motor CBs in PINK1 mutants could
have resulted from more discrete functional defects in electron transport chain (ETC)
complex I, rather than overall organelle senescence. To determine this, the yeast
alternative NADH oxidoreductase Ndi1p (NDI1) (Vilain et al., 2012) was overexpressed
in PINK1 loss of function mutants (Figure 3. 5Av,Ax,B). NDI1 overexpression partially
rescued the mitochondrial morphology in motor CBs of PINK1 mutants indicating that
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ETC complex I functional defects could underlie the morphological changes (Figure
3.5Av,Ax,B).

Figure 3.5 PINK1 mutants show abnormal mitochondrial morphology in motor
neuron CBs.
(A) Images show mitochondrial morphology in motor neuron CBs of ventral ganglion in
PINK1RV as control (i), PINK1B9 (ii), B9;P(Pink1) (genomic rescue) (iii), B9;Parkin OE
(iv), B9;NDI1 OE (v), PINK15/+ as control (vi) for PINK15 mutants (vii), PINK15;P(Pink1)
(genomic rescue) (viii), PINK15;Parkin OE (ix), and PINK15;NDI1 OE (x). Arrows in
PINK1B9 and PINK15 mutants indicate abnormal, rounded mitochondria, in contrast to
interconnected, reticular mitochondria in PINK1RV and PINK15/+ controls. Scale bar,
5µm. B, CBs (%) with abnormal, large round mitochondria were quantified for PINK1RV,
PINK1B9, B9;P(Pink1) (genomic rescue), B9;Parkin OE and B9;NDI1 OE and for
PINK15/+, PINK15, PINK15;P(Pink1) (genomic rescue), PINK15;Parkin OE and
PINK15;NDI1 OE. The mitochondrial morphology phenotype observed in PINK1 loss of
function mutants was rescued by the expression of genomic levels of P(Pink1) or by
parkin OE or by yeast alternative NADH oxidoreductase Ndi1P OE (NDI1 OE). Number
of larvae analyzed is shown on each bar. Error bars indicate SEM. *p < 0.05, **p < 0.01,
***p < 0.001 (nonparametric Kruskal–Wallis test with Dunn’s post-test); ns, nonsignificant
difference.
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3.5 Mitochondrial Density is not affected in PINK1 Loss of Function Mutants
One prediction of the PINK1 model of mitochondrial quality control (Youle and
Narendra, 2011, Ashrafi and Schwarz, 2013) is that defective turnover should cause
senescent mitochondria to accumulate in PINK1 mutant axons. Thus, I determined
whether the loss of PINK1 causes an increased mitochondrial density in larval SN
axons. Interestingly, I observed no significant change in the PINK1 mutants compared
with wild-type (Figure 3.6A). This result could be explained if most mitochondrial quality
control and turnover processes were localized to CBs. I therefore determined the
mitochondrial volume in motor CBs of the ventral ganglion using 3D reconstruction of
confocal images and found that, here too, the mitochondrial volume was very similar
between PINK1 mutants and wild-type animals, giving no indication of accumulation of
senescent organelles (Figure 3.6B).

Figure 3.6 PINK1 loss does not lead to accumulation of mitochondria to higher
densities in axons or CBs. A, Loss of PINK1 does not result in an increase in
mitochondrial density in motor axons. B, Mitochondrial density in motor neuron CBs also
remains unchanged in PINK1 mutants compared with PINK1RV control for PINK1B9 and
PINK15/+ control for PINK15. Number of larvae analyzed is indicated on each bar. Error
bars indicate SEM; one-way ANOVA with Bonferroni’s post-test, all are nonsignificant
(ns); mutants compared with wild-type or control and PINK1;P(Pink1) or PINK1;Parkin
OE compared with PINK1 mutants.
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CHAPTER 4. DISCUSSION

Mitochondria are semiautonomous organelles with a complex life cycle
encompassing biogenesis, transport, fission-fusion, and turnover. All these events of the
mitochondrial life cycle are carried out in a coordinated fashion so as to maintain a highly
functional mitochondrial population in cells. This is complicated further in neurons
because of their large dimensions and functionally compartmentalized cell structure:
synaptic end terminals with high energy demands are separated in space from the
somatic compartment, where protein synthesis and degradation occur, by extremely long
axons. Thus, neurons rely on axonal transport to re-distribute mitochondria over long
distances, which may separate, in time and space, events that are closely coordinated in
cells of more modest dimensions. However, a coherent model of mitochondrial turnover
in neurons and its potential failures in neurodegenerative disease has arisen from
studies involving PINK1/Parkin pathway. Inhibition of

this pathway produces

mitochondrial structural and functional defects in Drosophila muscle (Clark et al., 2006;
Park et al., 2006; Morais et al., 2009) and mouse striatum (Gautier et al., 2008). In
addition, PINK1 and parkin have been proposed to have a role in the segregation of the
dysfunctional mitochondria for turnover by preventing their fusion with healthy ones via
degradation of the mitochondrial fusion protein, Mfn (Poole et al., 2010; Ziviani et al.,
2010). Furthermore, PINK1 has been proposed to play a regulatory role in axonal
mitochondrial motility, by targeting the motor-organelle linker protein Miro for
degradation and thus halting the transport of dysfunctional mitochondria (Wang et al.,
2011; Liu et al., 2012).
However, the role of PINK1/Parkin pathway in mitochondrial turnover has not
been elucidated in the nervous system in vivo, under normal physiological conditions. In
addition, very little is understood about the changes that occur in the mitochondrial life
cycle when mitochondrial turnover is disrupted, particularly in neurons. If the proposed
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model mechanisms of the PINK1 pathway in mitochondrial quality control are broadly
valid in the complex environment of the nervous system, then they generate several
specific phenotypic predictions: failures of turnover, accumulation of senescent
mitochondria in the axons, defects in mitochondrial traffic, and a significant shift in the
mitochondrial fission-fusion steady state. I have tested these predictions in vivo, by
quantitatively determining mitochondrial membrane potential, density, motility behavior,
and morphology within the Drosophila larval nervous system in PINK1 deletion mutants.
Loss of PINK1 function causes a reduction in mitochondrial membrane potential in
nervous system in vivo, consistent with proposed role of PINK1 in mitochondrial quality
control, but does not cause the predicted increase in density or length in axons.
However, PINK1 deletion causes large rounded abnormal mitochondrial morphology in
cell soma. In addition, deletion or overexpression of PINK1 does not alter the balance
between stationary and moving mitochondria in axons, contrary to the popular model of
PINK1 in the degradation of Miro. Moreover, loss of PINK1 function disrupts the
bidirectional mitochondrial transport specifically by increasing the pause times of
anterograde mitochondria, and decreasing the velocities of retrograde mitochondria.
These specific, differential effects on motility patterns of anterograde, and retrograde
mitochondria have resulted in their reduced flux. Thus, my findings suggest that PINK1
is required to maintain the normal mitochondrial metabolic state and bidirectional
transport in axons, and for normal morphology in the CB, but not for regulating
mitochondrial fusion or turnover in axons.
4.1 Mitochondrial quality control does not show the expected signs of impairment
in axons of PINK1-deficient nervous system
Based on the proposed role of PINK1 in the tagging and turnover of senescent,
depolarized mitochondria (Matsuda et al., 2010; Narendra et al., 2010), I tested the
hypothesis that the loss of PINK1 function causes the dysfunctional mitochondria with
low inner membrane potential (IMP) to accumulate in axons of the PINK1-deficient
nervous system. The effect on IMP could manifest either as a general diminution of the
mean IMP of the mitochondrial population or as a distinct outlying population with a
significantly lower IMP. I observed the former (a modest reduction in IMP of the axonal
mitochondrial population overall) and not the latter (Figure 3.1). This is consistent in part
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with the proposed role of PINK1 in turnover and may reflect a protracted failure to cull
neuronal mitochondria, whereas the appearance of a distinct outlying population with low
IMP might be expected after short-term, acute PINK1 suppression. However, if
senescent mitochondria accumulate in the axons of PINK1-deficient neurons, as
predicted, then this should also have been apparent as both an increased density of
mitochondria and a net diminution of their retrieval via retrograde transport to the cell
body, a major site of turnover. However, I observed that mitochondrial density remains
unchanged in the axons of PINK1-deficient neurons (Figure 3.6A). Though there was a
reduction in retrograde delivery of mitochondria to cell body, I also observed the reduced
entry of mitochondria anterogradely into axons. These changes in retrograde traffic were
almost exactly balanced by those of anterograde mitochondria (Figure 3.2B,C), and did
not cause an expected increase in organelle density in the axons of PINK1-deficient
nervous system.
In addition, it is notable that if the current model of the mitochondrial life cycle is
correct, then senescent mitochondria should manifest themselves as a small
subpopulation with large inner membrane depolarization, available to be recognized and
tagged by PINK1 for turnover. However, this study and others (Verburg and Hollenbeck,
2008) have found that, under normal physiological conditions, neurons display a striking
lack of variation in IMP among the mitochondria within a cell, and there is certainly no
evidence for a small outlying population with low IMP. Even in Drosophila
neurodegenerative disease models, only animals with severe dying-back neuropathy
displayed gross depolarization of axonal mitochondria (Shidara and Hollenbeck, 2010).
Also, in contrast to the localization of PINK1/Parkin onto majority of mitochondria
reported in non-neuronal cells treated with uncouplers (Matsuda et al., 2010; Narendra
et al., 2010), studies in neurons found that parkin is targeted to only a small fraction of
depolarized mitochondria after photodamage or drug treatment (Ashrafi et al., 2014).
Indeed, recent data show that this discrepancy in evidence for parkin recruitment to
mitochondria in neuronal versus non-neuronal cells can be attributed to cell type-specific
differences in bioenergetics (Van Laar et al., 2011). Upon treatment with uncouplers,
parkin translocation to mitochondria was observed only in immortalized cell lines
including HeLa cells and SH-SY5Y neuroblastoma cells that mainly depend on glycolysis
for ATP, but not in neurons that depend on mitochondrial OXPHOS for ATP. However,
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when HeLa cells were made to depend on mitochondrial ATP synthesis by growing in
glucose-free, galactose-containing medium, CCCP treatment did not induce parkin
translocation to mitochondria (Van Laar et al., 2011). Similarly, when yeast was cultured
in non-fermentable carbon source and made to depend on mitochondrial respiration for
ATP, mitophagy was not induced (Kanki and Klionsky, 2008). These results suggest that
cellular bioenergetics play a very important role in the differential recruitment of parkin to
mitochondria in cell type-specific manner, and thereby in the induction of mitophagy.
Along with my data, this argues against a role for the PINK1-Parkin pathway in axonal
mitochondrial turnover in the nervous system in vivo.
An additional major proposed role of the PINK1 pathway in mitochondrial quality
control is the regulation of the fission–fusion steady-state. Down-regulation of
mitochondrial fusion protein opa1 has been shown to rescue the mitochondrial structural
defects in PINK1-deficient Drosophila muscle (Poole et al., 2008). In addition, higher
levels of the mitochondrial fusion protein mitofusin were detected in the PINK1-deficient
tissue (Poole et al., 2010; Ziviani et al., 2010). Thus, it has been hypothesized that
PINK1 targets the mitofusin of depolarized mitochondria for degradation, thus preventing
fusion of senescent, low IMP mitochondria with other, fully functional neighbors (Poole et
al., 2010), and thereby preserving the health of the population. Any imbalance of
mitochondrial fusion–fission processes in axons will be apparent in mitochondrial
morphology, as either longer mitochondria due to excessive fusion or small fragmented
mitochondria due to higher rates of fission (Amiri and Hollenbeck, 2008; Cagalinec et al.,
2013). Thus, PINK1 mutants should display increased mitochondrial length, apparent
either as a change in the population mean or perhaps only as an outlying, longer
senescent population. Here, too, I found no evidence for this prediction in vivo: the mean
mitochondrial lengths between normal and PINK1 mutant axons were identical for both
moving and stationary organelles, and there was no outlying-longer population in the
absence of PINK1 (Figure 3.4E). It has been shown in pancreatic cells that only healthy,
functional mitochondria undergo the fusion process (Twig et al., 2008a). This report has
shown that depolarized mitochondria are selectively inhibited from fusing with the
functional mitochondrial network, and this is achieved by the degradation of
mitochondrial fusion protein Opa1 (Twig et al., 2008a). However, in PINK1 mutants, a
reduction in mitochondrial IMP seems unlikely to inhibit the fusion, as these mitochondria
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do not show a drastic reduction in IMP, but rather a partial depolarization. Alternatively, it
is possible that mitochondrial fusion-fission occurs only rarely in axons. Indeed, it has
been recently reported that the rate of fusion-fission occurs at ~6 fold lower rate in axons
compared to the somatic compartment (Cagalinec et al., 2013).
4.2 Location of mitochondrial turnover
Although the loss of PINK1 function does not affect mitochondrial morphology in
motor axons, it is important to recognize that mitochondrial fusion–fission, and other
quality control processes, probably occur only rarely in axons (Berman et al., 2009;
Cagalinec et al., 2013). Despite clear evidence of axonal mitochondrial turnover in
embryonic neurons in culture (Maday et al., 2012), it remains likely that much of the
mitochondrial processing in the intact nervous system actually occurs in the somatic
compartment (Cai et al., 2012). In this case, I would expect PINK1 deficiency to produce
a phenotype not in axons, but mainly in the CBs. I did indeed observe that PINK1deficient CBs frequently contained large, rounded, abnormal mitochondria that are rarely
seen in the normal nervous system (Figure 3.5). This could reflect defects in biogenesis,
fission–fusion, turnover or some combination of these. Similar mitochondrial morphology
has been reported in adult Drosophila dopaminergic neurons of PINK1 mutants, well
before the stage of neuronal degeneration (Park et al., 2006). Moreover, the rescue of
mitochondrial morphology by yeast NDI1 OE in larval motor neurons, as I observe, or by
mitochondrial SOD2 overexpression in adult dopaminergic neurons of PINK1 deletion
mutants (Park et al., 2006; Koh et al., 2012), argues for a connection between
mitochondrial function and underlying morphological changes. It was notable, however,
that, in the absence of PINK1, I did not observe the predicted increase in mitochondrial
volume in CBs, which would result from defective turnover. Along with these data, the
reduced entry of anterograde mitochondria into axons that I observed in mutants argues
for a PINK1 role in mitochondrial biogenesis in the CB, possibly by interacting with the
Parkin – PARIS (ZNF746) – PGC-1α pathway (Shin et al., 2011). PARIS, a zinc-finger
protein has been shown to act as a transcriptional repressor of PGC-1α that works as a
transcriptional co-activator of genes required for mitochondrial biogenesis (Shin et al.,
2011). In this study, elevated levels of PARIS are observed in mice with parkin
knockdown. Consistent with this result, biochemical studies have also demonstrated that
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PARIS protein levels are regulated by parkin via ubiquitination, and thereby targeting it
for degradation by ubiquitin-proteasomal system (Shin et al., 2011). Parkin’s ubiquitin
ligase activity has been shown to require phosphorylation by PINK1 (Matsuda et al.,
2010), thus PINK1 could have a role in mitochondrial biogenesis via a Parkin – PARIS
(ZNF746) – PGC-1α pathway (Shin et al., 2011). Having a role in both mitochondrial
biogenesis and turnover, PINK1-Parkin pathway could play a very important regulatory
role in the maintenance of constant mitochondrial number, essential for the survival of
neurons.
Another proposed mechanism for PINK1-dependent mitochondrial quality control
that is consistent with my in vivo data is one by which organelle components are
repaired or replaced piecemeal, as required. Recent studies suggest a role for PINK1 in
the maintenance of ETC complex I activity by phosphorylation (Morais et al., 2009; Vilain
et al., 2012; Morais et al., 2014). Moreover, the complex I deficits in Drosophila PINK1
mutants are rescued by overexpression of the mitochondrial chaperone TRAP1 (Costa
et al., 2013; Zhang et al., 2013). In addition, misfolded proteins belonging to
mitochondrial ETC complexes are accumulated in Drosophila PINK1 mutants (Pimenta
de Castro et al., 2012) implying the role of PINK1 in maintaining the activity of
chaperones. Furthermore, the PINK1/Parkin pathway has been shown to be involved in
the selective elimination of damaged mitochondrial ETC proteins (Vincow et al., 2013).
All these studies indicate the role of PINK1 in the maintenance of ETC proteins, and
chaperones required for mitochondrial protein quality control. Thus, in neurons it is
possible that the PINK1-Parkin pathway preserves mitochondrial function upstream of a
role in overall mitochondrial turnover. This could include the maintenance of normal
metabolism and ATP production, the failure of which could explain many aspects of the
PINK1-deficient phenotypes I observe in vivo. I suggest that mitochondrial turnover via
tagging and digestion of senescent organelles may be rare in mature axons. In this
context, it is worth noting the recent in vivo evidence that axonal mitochondria can be
degraded alternatively in adjacent glial cells following axonal evulsion (Davis et al.,
2014). From the analyses of electron microscopic sections of mouse optic nerve head,
this study has demonstrated the delivery of axonal mitochondria via axonal membranous
extensions into astrocytic processes. This delivery process is visualized by specifically
expressing mitochondrially targeted fluorescent reporter only in retinal ganglion cells
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(RGCs). The axonal mitochondrial reporter has been observed to colocalize substantially
with lysosomes of astrocytes suggesting that axonal mitochondria are delivered for
turnover in astrocytes (Davis et al., 2014).
4.3 Mitochondrial transport is disrupted in PINK1-deficient nervous system
Based on studies involving in vitro cell cultures treated with mitochondrial
uncouplers, PINK1 is proposed to have a role in targeting depolarized mitochondria for
turnover. In contrast to non-neuronal cells, one complex issue in neurons is that
mitochondria spend the majority of their life-time in axons, and have to be transported to
the site of turnover, the cell soma. If PINK1 has a role in mitochondrial turnover in
nervous system in vivo under normal physiological conditions, then the loss of PINK1
function should cause a failure in tagging of dysfunctional mitochondria in axons, and
thereby reduction in their retrograde retrieval to the cell body for turnover. However, in
PINK1 deletion mutants I observed a reduction not just in retrograde flux but also in
anterograde flux. Interestingly, I found that these defects in flux have arised due to the
differential effects of the loss of PINK1 on the motility behavior patterns of anterograde,
and retrograde mitochondria. In PINK1 deletion mutants, velocities of retrograde
mitochondria are specifically reduced, however leaving those of anterograde
mitochondria unaffected. This suggests that PINK1 is probably involved in regulating the
activity of dynein motor, as velocities indicate the motor activity. Recently, it has been
shown that the abnormal activity of CDK5 in response to stress specifically disrupts the
retrograde axonal transport via the phosphorylation of Ndel/Lis1 complex that regulates
dynein motor (Klinman and Holzbaur, 2015). I propose that the specific effect on
retrograde velocities in PINK1 mutants could possibly involve the regulation of dynein
motor by the upregulated activity of CDK5 in response to stress.
In addition, the duty cycles of only anterograde mitochondria are reduced: with a
reduced fraction of time spent moving anterogradely, and a greater fraction of time in
pauses, thereby reducing their processive anterograde motility. Anterograde motility has
been shown to be regulated by multiple kinases via phosphorylation of motor protein
subunits (Morfini et al., 2002; Morfini et al., 2004; Morfini et al., 2009b). A recent study
has reported the elevated levels of GSK3β activity in the absence of PINK1 (Anichtchik
et al., 2008). GSK3β has been shown to specifically inhibit the anterograde movement
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via phosphorylation of kinesin light chain (KLC) that releases the kinesin-1 motor from
organelle (Morfini et al., 2004). Thus, the specific disruption of anterograde mitochondrial
motility in PINK1 mutants could possibly involve the regulation of organelle movement by
GSK3β.
4.4 Manipulation of the PINK1 pathway fails to control the stationary-motile
balance in the axon
A prominent hypothesized mechanism for regulating axonal mitochondrial motility
proposes that PINK1 tags mitochondria with low IMP to induce degradation of their
motor-organelle linker protein, Miro (Wang et al., 2011). According to this proposed
model, I expect PINK1 OE to cause the recruitment of retrogradely moving mitochondria
into stationary population or to cause complete cessation of movement. However, I
observed that PINK1 OE(2) actually increases the percentage of retrogradely moving
population and the overexpression of PINK1 or parkin in single copy do not alter the
percentages of moving and stationary mitochondria (Figure 3.3C).
In addition, I tested this proposed role of PINK1 in Miro degradation using PINK1
deletion mutants. I hypothesized that PINK1 mutants would show enhanced transport
and reduced pause times. However, I observed the opposite: PINK1 mutation disrupted
the mitochondrial traffic specifically by increasing the pause times of anterograde
mitochondria, and decreasing the velocities of retrograde mitochondria. Furthermore, I
did not observe an increase in the percentage of moving mitochondria in PINK1 deletion
mutants, and the fractions of stationary and motile mitochondria remain unaffected
(Figure 3.3B). Thus, my analysis of mitochondrial motility suggests that PINK1 has a role
in mediating the specific motility behaviors of both anterograde and retrograde
mitochondria. It is possible that the use of PINK1-null mutants in my studies, rather than
a PINK1 RNAi line (Wang et al., 2011; Liu et al., 2012), could account for different
findings in mitochondrial motility. Because PINK1 OE is reported to completely halt
motility in CCAP neurons (Wang et al., 2011), but not in motor neurons (Figure 3.3C)
(Liu et al., 2012), it is also possible that PINK1 OE produces neuronal cell type-specific
phenotypes. It is also notable that, in all reports, disruption of normal PINK1 levels
affected not just anterograde motility, but also retrograde. Indeed, many studies of the
modulation of axonal transport also show that experimental interventions ostensibly
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targeted at one direction of movement actually yield effects on both directions (e.g.,
Pilling et al., 2006; Morfini et al., 2009b; Pigino et al., 2009; Russo et al., 2009; Morfini et
al., 2013). Thus, the mechanisms of axonal transport regulation are complex and do not
seem to involve a general PINK1-induced halting of anterograde traffic in vivo.
In summary, I found that mitochondrial membrane potential is diminished in
PINK1-deficient nervous system indicating the role of PINK1 in the maintenance of
normal mitochondrial function. However, PINK1-deficiency has not resulted in an
increase in axonal mitochondrial density as predicted based on the proposed role of
PINK1 in tagging mitochondria for turnover. In addition, loss of PINK1 function caused a
reduction in both anterograde and retrograde mitochondrial traffic with more specific,
essentially balanced effects. Manipulation of PINK1 levels either by deletion or
overexpression did not alter the balance between stationary and moving mitochondria,
as opposed to the proposed model of PINK1 in the degradation of Miro. Furthermore, I
did not observe an increase in mitochondrial length in axons as predicted from the
hypothesized role of PINK1 in the segregation of dysfunctional mitochondria by
preventing their fusion with healthy ones. However, PINK1 loss of function caused an
abnormally large rounded mitochondria in neuronal soma in vivo. Surprisingly, PINK1
deletion did not result in the predicted increase in mitochondrial volume in neuronal
soma which is presumed to be the major site of turnover. Thus, these results suggest
that PINK1 is required for the maintenance of a normal mitochondrial network in the
soma in vivo, indicating that it plays a role there in mitochondrial biogenesis and/or
fission–fusion processes.
In conclusion, my findings indicate that PINK1 is required for normal
mitochondrial function and bidirectional axonal transport, but not for mitochondrial
turnover or fission–fusion control in axons in vivo as recently proposed (Youle and
Narendra, 2011; Ashrafi and Schwarz, 2013). Thus, my results support the idea that
mitochondrial turnover and fission–fusion in axons are organized differently in vivo, in an
intact nervous system, than they are in vitro, in neuronal culture.
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